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RESUMO 
Acinetobacter baumannii é un patóxeno nosocomial que posúe unha enorme capacidade 
de adaptarse a condicións desfavorables, o que o converte nun importante problema de 
saúde pública.  
Os perfís de expresión xénica durante a formación de biopelículas en A. baumannii 
resultaron diferentes en comparación con células libres planctónicas en fase exponencial e 
estacionaria. Confirmouse que os xenes A1S_1507, A1S_3168, A1S_2042, A1S_0302 y 
A1S_0114 que codifican unha proteína de fimbria, una proteína dun pilus, un regulador 
transcripcional, unha proteína hipotética e un transportador de grupos acilo, 
respectivamente, están implicados na capacidade de formación de biopelículas en A. 
baumannii. Ademais, demostrouse que o xene A1S_0114 participa na adherencia a 
superficies bióticas e abióticas, en virulencia e na síntese dun metabolito denominado 
acinetin 505. 
Así mesmo, atopáronse moléculas de sRNAs que se expresan diferencialmente nas 
biopelículas con respecto ás células planctónicas. Entre eles, destacou o sRNA 13573, 
altamente expresado en células sésiles, que resultou estar implicado na formación de 
biopelículas e na adherencia a células eucariotas. 
Neste traballo, descríbense, dúas novas dianas terapéuticas que participan na patoxénese 
de A. baumannii: o xene A1S_0114 e o sRNA 13573. 
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RESUMEN 
Acinetobacter baumannii es un patógeno nosocomial que posee una enorme capacidad de 
adaptarse a condiciones desfavorables, lo que lo convierte en un importante problema de 
salud pública.  
Los perfiles de expresión génica durante la formación de biopelículas en A. baumannii 
resultaron diferentes en comparación con células libres planctónicas en fase exponencial 
y estacionaria. Se confirmó que los genes A1S_1507, A1S_3168, A1S_2042, A1S_0302 
y A1S_0114 que codifican una proteína de fimbria, una proteína de un pilus, un regulador 
transcripcional, una proteína hipotética y un transportador de grupos acilo, 
respectivamente, están implicados en la capacidad de formación de biopelículas en A. 
baumannii. Además, se demostró que el gen A1S_0114 participa en la adherencia a 
superficies bióticas y abióticas, en virulencia y en la síntesis de un metabolito 
denominado acinetin 505. 
Asimismo, se encontraron moléculas de sRNAs que se expresan diferencialmente en las 
biopelículas con respecto a las células planctónicas. Entre ellos, destacó el sRNA 13573, 
altamente expresado en células sésiles, que resultó estar implicado en formación de 
biopelículas y en la adherencia a células eucariotas. 
En este trabajo, se describen, dos nuevas dianas terapéuticas que participan en la 
patogénesis de A. baumannii: el gen A1S_0114 y el sRNA 13573. 
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ABSTRACT 
Acinetobacter baumannii is a nosocomial pathogen with a notable ability to adapt to 
stress conditions and develop resistance to multiple antimicrobial compounds, becoming 
a remarkable public health problem.  
Gene expression during biofilm formation in A. baumannii showed different profiles 
compared to planktonic cells in exponential and stationary phase of growth. We could 
confirm that genes A1S_1507, A1S_3168, A1S_2042, A1S_0302 y A1S_0114 coding a 
fimbrial protein, a pilus assembly protein, a transcriptional regulator, a hypothetical 
protein and an acyl-carrier protein, respectively, are involved in biofilm formation ability 
of A. baumannii. Furthermore, the A1S_0114 gene showed to play a role in attachment to 
biotic and abiotic surfaces, in virulence, and in the biosynthesis of a metabolite named as 
acinetin 505. 
Moreover, an important number of sRNAs differentially expressed in biofilm associated 
cells compared to planktonic cells were determined. Among them, the 13575 sRNA, 
highly expressed in biofilm, resulted to be involved in biofilm formation and in adherence 
to eukaryotic cells. 
In the present work, two new therapeutic targets involved in the pathogenesis of A. 
baumannii are described: the A1S_0114 gen and the 13573 sRNA. 
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According to World Health Organization, infectious diseases are responsible of almost 
30% of the 56 million deaths estimated per year worldwide (1). By the end of World War 
II, it was thought that microbial infections were under control due to the discovery and 
mass-production of penicillin and the efficiency of vaccines available (2). Since then, the 
access to potent and safe antimicrobial agents reduced the morbidity and mortality 
associated with formerly fatal diseases (3).  
However, nowadays some infectious diseases are considered as a remarkable public 
health problem, both in developing and developed countries. The misuse of antibiotics 
has been associated with the adaptation of bacteria to these drugs and the subsequent 
emergence of multidrug resistant (MDR) strains. This fact is especially dangerous in 
hospital environments, wherein patients with compromised immune system are 
particularly vulnerable to infectious diseases. About a million people acquire some type 
of nosocomial infection in the United States every year and 75,000 die as a result (4). The 
growing number of antimicrobial-resistant pathogens, which are associated with 
nosocomial infection, suppose a significant burden on healthcare systems and have 
important economic costs (5). 
The pathogens that currently cause the majority of hospital infections and effectively 
avoid the action of antibacterial drugs are known as “ESKAPE” pathogens. This group is 
formed by Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (3). 
Increasing rates of infection due to methicillin-resistant S. aureus, vancomycin-resistant 
E. faecium and pandrug resistant (PDR) Gram-negative pathogens such as Acinetobacter 
species or P. aeruginosa, leaves clinicians without therapeutic options being forced to use 
previously discarded drugs, such as colistin. Although this antibiotic causes 
nephrotoxicity, it is considered a last-line therapeutic option for infections caused by 
MDR A. baumannii (6, 7). The absence of new compounds effective against these 
pathogens would have a terrible effect on public health. Thus, it is necessary to find new 
targets that would allow us to design new therapeutic tools for treating infections caused 
by MDR bacteria. 
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1.1. Genus Acinetobacter 
Acinetobacter is a genus of Gram-negative bacteria belonging to the family 
Moraxellaceae within the order of Gammaproteobacteria. It comprises strictly aerobic, 
non-fermenting, non-motile, catalase-positive, oxidase-negative organisms with a DNA 
G+C content of 39% to 47%. The cells are 1.5 µm in length, with a shape varying from 
coccoid to coccobacillary (8). Members of this genus are considered ubiquitous 
organisms and can be recovered from different kind of samples of soil and water. Most 
Acinetobacter strains are metabolically versatile and able to grow in a simple mineral 
medium. Many species of this genus have also been recovered from human clinical 
specimens and have some significance as human pathogens considering that they cause a 
number of nosocomial infections (9, 10). 
The first organism of this genus was described in 1911 by Beijerinck, who named it as 
Micrococcus calco-aceticus, and it was isolated from soil by enrichment in a  calcium-
acetate-containing minimal medium (11). Since then, members of the genus have been 
classified under a variety of different names till 1954, when Brisou and Prévot proposed 
the current designation (12). However, when Baumann et al. published their 
comprehensive study based on nutritional and biochemical properties, this classification 
became more widely accepted (13). One of the biggest improvements on the history of 
this genus was in 1986, when Bouver and Grimont distinguished 12 genospecies based on 
DNA-DNA hybridization studies (14). Currently, the genus comprises 56 species with 
valid names (http://www.bacterio.net/acinetobacter.html, last accessed May 2018). 
Six of these species, including A. baumannii, A. calcoaceticus, A. nosocomialis, A. pittii, 
A. seifertii and A. dijkshoorniae, are very closely related and difficult to distinguish by 
phenotypic properties so it has been proposed to refer to these species as the A. 
calcoaceticus-A. baumannii complex (ACB). Indeed, taxonomic studies based on DNA-
DNA hybridization, as well as comparison of housekeeping gene sequences or genome-
wide analysis, demonstrated that the ACB complex represents a phylogenetically well-
defined subgroup within the genus (15-18). This group of organisms comprises the most 
clinically relevant species that have been implicated in the majority of both community 
acquired and nosocomial infections caused by these pathogens (9). 
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Acinetobacter spp. are among the most frequent causes of hospital-acquired bacterial 
infections, being considered responsible for 2-10% of all Gram-negative hospital 
infections (19). Furthermore, the incidence of infection due to MDR strains of this genus 
continues to increase globally (6). They have been involved in a wide range of infections, 
particularly in critically-ill patients with impaired host defences, including pneumonia, 
skin and soft-tissue infections, wound infections, urinary tract infections, meningitis, and 
bloodstream infections (20).  
The most important human pathogen of this group is A. baumannii, which is often 
encountered in intensive care units and in long-term care facilities (21). As mentioned 
above, it has been classified by the IDSA (Infectious Diseases Society of America) as one 
of the six most important multidrug resistant microorganisms in hospitals worldwide (6). 
 
1.2. Acinetobacter baumannii 
 
A. baumannii is a non-fermentative, 
oxidase-negative, non-flagellated Gram-
negative coccobacillus. It is commonly 
isolated from medical environments and 
equipment, medical personnel, and 
hospitalized patients. This 
microorganism is considered as highly 
prevalent in nature and as well as a 
common component of human flora. 
However, A. baumannii is not a 
ubiquitous organism and strains from this species are mainly isolated from medical 
environments and hospitalized patients (22, 23). The ability of A. baumannii to resist 
desiccation and persist on hospital environments together with the facility to develop 
resistance to multiple antimicrobial agents were the main causes of the emergence of this 
bacterium as a relevant human pathogen (24). 
Figure 1. SEM image of A. baumannii ATCC 17978. 
50000x 
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Multiple studies indicate that A. baumannii intrinsically has a higher virulence potential 
than other Acinetobacter spp. Peleg et al. showed that A. baumannii strains were more 
letal to the wax moth larva of Galleria mellonella than strains of A. baylyi and A. lwoffii 
(25). In a different study, all the strains of A. baumannii tested were lethal in neutropenic 
mice, unlike A. junii, which was nonlethal (26). Comparison of clinical outcomes in 
patients infected with A. nosocomialis, A. pittii and A.baumannii resulted in a nearly 9-
fold reduction in mortality in non-baumannii species compared to A. baumannii. Similar 
results were found using a G. mellonella model (27). 
 
1.2.1. Clinical relevance 
A. baumannii causes a wide variety of infections. Most of the cases involve the 
respiratory tract, although bacteraemia, urinary tract infections, endocarditis, meningitis, 
and wound infection may also occur (28). A study performed in Spain in 2010 showed 
that the predominant type of infection caused by this pathogen was pneumonia (38.4%), 
followed by skin infection (20.5%), tracheobronchitis (9.9%), urinary tract infection 
(9.9%), and intraabdominal infection (9.9%) (24). Infections are more common in 
patients suffering from an underlying disease or who have undergone major surgical 
problems. A. baumannii can easily enter the body through open wounds, intravascular 
catheters and mechanical ventilators, which facilitate the establishment of an infection 
(19). 
Hospital-acquired pneumonia occurs most typically in patients receiving mechanical 
ventilation in the intensive care setting. The crude mortality of ventilator-associated 
pneumonia caused by A. baumannii has been reported to be between 40% and 70% (29-
31), although it is controversial whether this mortality is directly attributable to this 
pathogen. However, several studies have concluded that nosocomial infection caused by 
A. baumannii is associated with increased attributable mortality (32, 33). 
 Mortality associated to severe A. baumannii infection is significantly high, especially 
when the isolate is resistant to carbapenems. Crude mortality for carbapenem-resistant A. 
baumannii infections ranges from 16 to 76% (34). In addition to clinical complications, 
the emergence of drug resistance has also resulted in an additional economic burden on 
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health systems (23). Risk factors contributing to mortality in patients with carbapenem-
resistant A. baumannii bloodstream infections include the severity of illness, underlying 
malignancy, presence of a catheter, intubation, history of transplant, higher age, septic 
shock, concurrent pneumonia, inappropriate antimicrobial therapy, prolonged ICU stay, 
and renal failure (35-37). 
A. baumannii is responsible for occasional sudden outbreaks that are difficult to control 
(38, 39). The local circumstances of clinical units and their environment determine the 
type of infection and the consequent risk of dissemination, which could cause an outbreak 
(40). Such outbreaks may be a reflection of the extreme pressure conditions that hospital 
emergency units have, leading to breakdowns in infection control procedures and to the 
epidemic spread of A. baumannii (19). 
Less commonly, A. baumannii may cause community-acquired infections, including 
pneumonia and bacteraemia. These type of infections are usually associated with alcohol 
abuse, diabetes, cancer or bronchopulmonary disease and mortality rates can be as high as 
60% (19, 20). A. baumannii has been also associated with infections subsequent to 
injuries in conflict areas, as Iraq or Afghanistan, or following natural disasters (40).  
 
1.2.2. Antibiotic resistance 
Multidrug resistant A. baumannii is recognized to be one of the most difficult 
antimicrobial resistant Gram-negative bacilli to control and treat. Aside from a big 
resistance island in its genome, A. baumannii has the capacity to rapidly acquire 
additional resistance genes from other bacterial species (41). This genetic plasticity 
allows this microorganism to adapt to stressful conditions and to develop antibiotic 
resistance, which may evolve into a multirresistant pattern following the acquisition of 
different resistance mechanisms (20, 42). The rapid global emergence of A. baumannii 
strains resistant to all β-lactams, including carbapenems, illustrates the potential of this 
organism to respond quickly to changes under selective environmental pressure (9). 
Reports describing infections caused by PDR strains that are resistant to all clinically 
used antibiotics are specially alarming and represent a challenge for clinicians treating 
infections caused by these strains (43-45). 
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Thanks to advances in sequencing and computational techniques, genomic comparative 
analyses of different strains have revealed the ability of A. baumannii to acquire genetic 
material that contributes to the pathobiology of the bacteria (23). The major resistance 
mechanisms that have been identified in A. baumannii are summarized in Table 1. 
Table 1. Major mechanisms of antimicrobial resistance in Acinetobacter baumannii. 
Antimicrobial 
agent 
Resistance mechanism Protein References 
β-Lactams Inactivating enzymes AmpC, CTX-M, OXA-23, 
-40, -51, NDM, VIM, IMP 
(46-52) 
 Decreased outer 
membrane protein 
expression 
CarO, Omp33-36 (53-55) 
 Efflux pumps AdeABC (56) 
 Altered penicillin-
binding protein 
 
PBP2 (57) 
Fluoroquinolones Target modification GyrA, ParC (58) 
 Efflux pumps 
 
AdeABC, AdeFGH (58, 59) 
Aminoglycosides Aminoglycoside 
modifying enzymes 
AAC, ANT, APH (60-62) 
 Ribosomal 
methylation 
ArmA (63, 64) 
 Efflux pumps 
 
AdeABC (65) 
Tetracyclines Ribosomal protection TetM (66) 
 Efflux pumps 
 
AdeABC, TetA, TetB (67) 
Rifampicin Target modification 
 
RpoB (68) 
Colistin Target modification 
 
PmrCAB (69) 
 
The most prevalent mechanism of β-lactam resistance is the enzymatic degradation by β-
lactamases. As penicillins, cephalosporins, and carbapenemes are included in the 
preferential treatments for many infectious diseases, the presence of these enzymes play a 
critical role in the selection of appropriate therapy (70). Most of A. baumannii clinical 
isolates are now resistant to cephalosporins, including those of third- and fourth-
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generation. The mechanism most frequently associated with resistance to cephalosporins 
is the over-expression of the chromosomal cephalosporinase AmpC (or ADC, 
Acinetobacter-derived cephalosporinase), related to the presence of the insertion sequence 
ISAba1 upstream of the gene (46, 71).  
In the recent past, carbapenems used to be the most adequate antibacterial agent used to 
treat A. baumannii infections. However, the resistance to these compounds has been 
recently reported with increasing frequency. The most significant mechanism of 
carbapenem resistance is the production of carbapenemases. These enzymes are β-
lactamases  that can be sorted into class A, B, C, or D, following Ambler classification 
(72), being the class D carbapenemases the most frequently found (73). Several 
phylogenetic subgroups of class B β-lactamases have been identified, including the 
chromosomally encoded and naturally produced OXA-51/69 and five clusters of acquired 
carbapenemases (OXA-23, -40, -58, -143, and -235) (74). Non-OXA carbapenemases 
have also been acquired by A. baumannii, such as NDM-1, that has been detected 
worldwide since 2011 (75). Furthermore, the production of TEM-1, a class A β-lactamase 
unable to hydrolyse carbapenems, has been associated with resistance to sulbactam, a β-
lactamase inhibitor used to mitigate the hydrolysis of ampicillin or cefoperazone by class 
A β-lactamases (76). 
β-Lactam resistance has also been attributed to nonenzymatic mechanisms (9). Thereby, 
changes in outer membrane proteins (OMPs) reduce the transport into the periplasmic 
space, limiting the access to penicillin-binding proteins (PBPs) and leading to resistance 
to these compounds (77). For example, the decreased expression of the outer membrane 
porin Omp33-36 and the loss of the porin CarO have been associated with carbapenem 
resistance (53, 54).  
The natural role of efflux pumps is to remove chemicals that could damage the 
membrane, but they have also the ability to expel a wide variety of antibiotics (77). The 
genome of a multidrug-resistant A. baumannii encodes also a wide variety of multidrug 
efflux systems (61), being the AdeABC a major mechanism of resistance with a broad 
substrate affinity that includes β-lactams, aminoglycosides, erythromycin, 
chloramphenicol, tetracyclines, fluoroquinolones, trimethoprim, or ethidium bromide (9, 
78). 
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The presence of genes coding for aminoglycoside-modifying enzymes is highly-prevalent 
in multidrug resistant A. baumannii strains where different classes of enzymes have been 
described, such as acetyltranferases, nucleotidyltransferases, and phosphotransferases 
(60). Another aminoglycoside resistance mechanism is the production of 16S ribosomal 
RNA methyltransferases that protects the 16S rRNA through the methylation of a guanine 
residue in the aminoglycoside-binding site (79). 
Also, single amino acid changes in proteins that are targets of different compounds may 
be responsible of a higher resistance profile. Thus, modifications in RpoB, GyrA and 
PmrCAB proteins cause resistance to rifampicin, fluoroquinolones or colistin, 
respectively, in A. baumannii (68, 69, 80). 
 
1.2.3. Pathogenicity and virulence factors 
A. baumannii has a unique ability in surviving in the hospital environment and in 
developing resistance to antibiotics, leading to troublesome hospital outbreaks and 
therapeutic challenges (81). New advances in genetics and molecular biology, such as 
genomic analyses, elaboration of gene knockout mutant strains, or transposon mutant 
libraries, have facilitated our understanding of its physiology and allow us to identify 
different virulence factors (82).  
The success of A. baumannii can be attributed to several factors such as its ability to form 
biofilm and its resistance to desiccation on abiotic surfaces. Biofilms are sessile 
communities formed by cells embedded in an extracellular matrix that confers resistance 
to numerous antimicrobial agents and products of the immune system (83). Thus, 
organisms that are able to grow in this sessile lifestyle are extremely difficult to eradicate. 
Furthermore, under desiccation conditions, A. baumannii undergoes morphological 
changes, such as thicker cell walls, that contribute to its persistence on solid surfaces (84). 
Ethanol also enhances the growth of the bacteria under high concentrations of salts, which 
increases the virulence of A. baumannii (85, 86). The ability of A. baumannii to adhere to 
host cells is also an important virulence factor since it is considered the initial step of the 
colonization and subsequent infection processes (87). Despite the etymology of the term 
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Acinetobacter (a-kineto, nonmotile), motility has been reported several years ago in this 
genus and it has been related to virulence although its role remains unclear (88, 89). 
 
1.2.3.1. Attachment and biofilm formation 
Bacteria have the ability to adhere to solid surfaces leading to a slippery coat. This mode 
of existence constitute a major component of the bacterial biomass in many different 
conditions (90). This biofilm is a structured consortium of bacteria embedded in a self-
produced polymer matrix consisting of polysaccharides, proteins and extracellular DNA 
(91). Biofilms are complex structures and constitute a protected mode of growth for 
bacteria that allows them to survive in a hostile environment. These sessile communities 
can promote the multiplication and dispersion of non-sessile individuals (83).  
 
Figure 2. Biofilm formation steps. Modified from Coughlan et al. 2016 (92). 
The process of biofilm formation is dynamic and complex and involves three stages 
(Figure 2). The first stage initiates with reversible attachment of bacteria to a favourable 
surface. Attachment occurs seconds after the bacterial cells detect the required 
environmental signals (93). During the maturation stage (second stage) the cell aggregates 
begin to grow in layers in a three-dimensional manner (94). This stage is mostly 
characterized by cell-to-cell interactions and the formation of important surface 
components that contribute to the structure of the biofilm (93). The third stage consists of 
detachment and dispersion. At this final step, sessile communities can give rise to 
planktonic bacteria that are able to rapidly multiply and disperse to colonize new surfaces. 
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The nutritional status of the environment usually dictates bacterial behaviour, including 
the biofilm dispersal response (95, 96). 
Bacteria embedded in biofilms exhibit a set of properties that differ substantially from 
free-living bacteria, mainly due to the structural and functional characteristics of the 
matrix that protects them (97). Bacterial biofilms are resistant to antibiotics, to 
disinfectant chemicals, to phagocytosis and to other components of the innate and 
adaptive inflammatory defense system of the host (91). Thus, a high number of chronic 
bacterial infections involve bacterial biofilms, which are not easily eradicated by 
conventional antibiotic therapy. Biofilm infections share clinical characteristics: biofilms 
grow slowly and symptoms associated with the infection show up late, sessile bacterial 
cells release antigens and stimulate the production of antibodies, but even in healthy 
individuals biofilm infections are rarely resolved by the host defense mechanisms (83). 
A. baumannii has a remarkable capacity to attach and adhere to medical devices, such as 
catheters, respiratory equipment, environmental surfaces, and has a notable ability to 
colonize both biotic and abiotic surfaces forming biofilms (98). Adherence to host cells 
represents the initial step of colonization or infection. Such capacity is in accordance with 
the reported ability of some strains to survive for a long time on abiotic surfaces under 
desiccation conditions (99).  
The adherence of A. baumannii to biotic and abiotic surfaces usually results in biofilm 
formation which, in turn, is related with persistence in medical environments and 
antimicrobial resistance, causing disease (23). Adherence and biofilm formation to both 
abiotic and biotic surfaces have showed a high variability among different strains (100, 
101). Furthermore, there are significant variations in the cell density and biofilm 
structures formed on these surfaces depending on the strains (101). These variations may 
be influenced by common factors such as nutrient availability, bacterial surface 
components, quorum sensing abilities, and regulatory networks (102). Growth 
temperature and concentration of extracellular free iron also affect the amount of biofilm 
formed on abiotic surfaces, as well as the presence of blue light and ethanol (86, 87, 103, 
104). 
Nowadays, a number of genes have been reported to play a role in adherence and biofilm 
formation on abiotic and biotic surfaces. However, there seems to be no direct correlation 
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between adhesion on host cells and biofilm formation on abiotic surfaces (98). A study 
comparing the ability to adhere to eukaryotic cells and to form biofilms of different 
strains reported that there is not a clear relationship between these two abilities (100).  
 Type I pili 
Type I pili are one of the most common protein structures present on the pathogen 
surfaces, playing a major role in adherence and/or biofilm formation of Gram-negative 
bacteria (105). One example is the csuE gene, which truncation causes a decrease in 
biofilm formation but does not affect the ability of the mutant strain to adhere to 
bronchial epithelial cells (106). This gene is part of the operon csuA/BABCDE, that 
encodes an usher-chaperone assembly system and mediates pilus production required for 
the initial steps of bacterial attachment on abiotic surfaces in A. baumannii ATCC 19606
T
 
(107). This operon is controlled by a two-component regulatory system that includes a 
sensor kinase encoded by the bfmS gene and a response regulator encoded by the bfmR 
gene. Inactivation of bfmR resulted in abolition of the whole operon expression, no pili 
production and loss of biofilm formation on plastic (108). Accordingly, experiments 
performed with a bfmS knockout strain showed that this sensor kinase mediates not only 
biofilm formation, but also adherence to biotic surfaces, serum resistance, and antibiotic 
susceptibility (109). 
Another type I pilus was found in the A. baumannii MAR002 clinical strain. This pilus 
showed to by encoded by the operon LH92_11070-11085, playing a role in biofilm 
formation and attachment to eukaryotic cells. The inactivation of the major subunit of this 
system, encoded by the LH92_11085 gene, significantly reduced bacterial attachment to 
human alveolar cells and biofilm formation on plastic surfaces (110). This gen, 
homologue to A1S_2091 from A. baumannii ATCC 17978, was described as one of the 
most abundant proteins present in the pellicle matrix of different clinical strains, together 
with proteins CsuA/B (111). The subunit encoded by the A1S_1510 gene, which is part of 
the fimbrial operon A1S_1510-1507, was also abundant in the pellicle samples (111). 
Taken together these data suggest that the above mentioned pili systems are essential for 
biofilm formation. 
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 Type V secretion systems 
The type V secretion systems encompasses the autotransporter proteins, the two-partner 
secretion system (TPS) and the type Vc family proteins. It has been reported that the TPS 
pathway mediates the translocation across the outer membrane of large effector proteins 
involved in interactions between the pathogens and their hosts (112). However, most of 
the autotransporter proteins remain to be characterized (113).  
The autotransporter Ata, a surface protein in the adhesion ability of A. baumannii, is 
critical for biofilm formation since its deletion resulted in a lower biofilm production 
(114). This protein also mediates the adhesion of bacterial cells to collagen type IV of 
eukaryotic cells, being demonstrated its role in virulence since mice infected with A. 
baumannii ATCC 17978 wild type strain resulted in higher levels of mortality than those 
mice infected with the ata-negative strains (114). 
The TPS AbFhaB/FhaC of A. baumannii AbH12O-A2 clinical strain was reported to be 
involved in adhesion since the inactivation of this system significantly decreased bacterial 
attachment to human alveolar cells. Moreover, the TPS AbFhaB/FhaC is implicated in 
fibronectin-mediated adherence and plays a role in A. baumannii virulence (115).  
 Membrane-associated proteins 
The bacterial adhesin Bap (biofilm-associated protein) was identified by Loehfelm et al. 
as an important factor for the development of mature biofilm structures (116). 
Transposon-mediated inactivation of bap gene leaded to a remarkable decrease in the 
biofilm thickness produced by the clinical strain A. baumannii 307-0294 (116). A 
different study proved that biofilm formation on abiotic surfaces by A. baumannii strains 
is inhibited using a Bap-specific antibody, confirming that this protein is expressed at the 
cell surface and that it is associated with biofilm formation (117). Bap has also been 
described as a surface structure involved in adherence to human bronchial epithelial cells 
and neonatal keratinocytes (118). 
One of the most abundant porins in the outer membrane, OmpA, has been described as 
implicated in attachment to plastic and in the interaction with human epithelial cells and 
Candida albicans filaments (119-121). In A. baumannii, OmpA is a well-characterized 
virulence factor as it has been shown to induce apoptosis in human epithelial cells, to 
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promote invasion of epithelial cells by interacting with fibronectin and to be necessary for 
persistence of the bacteria in the mouse lung (122-124). Furthermore, OmpA is involved 
in antimicrobial resistance and its disruption decreases the minimal inhibitory 
concentrations (MICs) of several antibiotics (125). 
 Surface polysaccharides 
Exopolysaccharides, apart from surface proteins, form a key component of A. baumannii 
biofilms. Poly-β-(1-6)-N-acetylglucosamine (PNAG) is the major polysaccharide polymer 
and it is synthesized by proteins encoded by the pgaABCD locus (126). Although the 
deletion of this locus has no effect on biofilm formation under static conditions, very 
striking differences were observed when cultures were grown with vigorous shaking, 
suggesting that PNAG may be essential for maintaining the integrity of the biofilm (126). 
PNAG has also been described as a virulence factor that protects bacteria against innate 
host defenses (102, 126). 
 Quorum sensing 
Cell population density is a mechanism used for bacteria to control adherence and biofilm 
formation (23). Quorum sensing is an important global regulatory system in bacteria that 
provides mechanism to coordinate the behaviour of individual bacteria in a population. In 
Gram-negative species, acyl-homoserine lactones (AHLs) are mainly employed as 
signalling molecules able to control biofilm formation (127). Luo et al. (128) showed that 
A. baumannii ATCC 19606
T
 cells cultured in the presence of N-Hexanoyl-L-homoserine 
lactone over-expressed the csuA/BABCDE genes and had higher biofilm densities than the 
control strain. Accordingly, the addition of a quorum quenching lactonase, an enzyme 
that degrades AHL, caused the disruption of biofilm formation in A. baumannii S1 strain 
(129). 
An autoinducer synthase coded by abaI gene was proved to be responsible for the 
production of AHL in A. nosocomialis strain M2 (130). The deletion of the above 
mentioned gene caused a decrease in the ability to form biofilm in the mutant strain 
compared to the wild type strain. Furthermore, the addition of ethyl acetate extract from 
wild type cells restored the capacity of the mutant strain to form normal biofilms, 
suggesting that this biofilm defect was due to a loss of AHL signal (130). 
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The production of AbaI-dependent AHL activated the transcription of A1S_0112-
A1S_0118 genes in A. nosocomialis strain M2 (131). This set of genes, along with 
A1S_0119, was predicted to be involved in the biosynthesis of a secondary metabolite 
(105, 131). Insertions in genes A1S_0112 and A1S_0115 in A. baumannii 17978hm made 
this strain unable to form pellicle, a specialised type of biofilm localised at the interface 
between air and liquid (132). 
 Environmental factors 
Different cues as temperature, light or concentration of extracellular free iron are relevant 
for the interaction of A. baumannii with the host and also affect the amount of biofilm 
formed (23). Blue light modulates biofilm and pellicle formation through blsA gene, 
which codes for a protein that carries a blue-light-sensing-using flavin domain and is an 
active photoreceptor protein (104). While the incubation of A. baumannii ATCC 17978 
for 4 days in LB at 24°C under blue light produced no biofilm on glass tube, this strain 
formed biofilm on the tube walls as well as pellicles when incubated under the same 
conditions in darkness (104).  
Other culture conditions as temperature, shaking or the surface material may vary the 
amount of biofilm formed by a strain, as Tomaras et al. reported (107). Thus, A. 
baumannii ATCC 19606
T
 formed more biofilm at 30°C than at 37°C, under stagnant 
conditions and in polystyrene or polypropylene tubes than in borosilicate ones (107). A 
recent study indicated that even though A. baumannii has the ability to form biofilm on 
different materials such as glass, porcelain, stainless steel, rubber, polycarbonate or 
polypropylene, the amount of biofilm formed varied significantly being polycarbonate the 
surface wherein more biofilm was developed (133). 
 
1.2.3.2. Motility 
The lack of flagellar genes in A. baumannii resulted in the assumption that this 
microorganism is unable to move or at least to show swarming motility, which is 
mediated by flagella (102). However, A. baumannii spreads rapidly over surfaces, 
probably due to twitching, and displays differential motility in response to different 
Introduction 
 
41 
 
factors (23). Movement on the surface of semi-solid media diminishes as the 
concentration of agar or agarose increases as well as different types of agar affect the 
motility response (101, 131, 134). Furthermore, different strains display different motility 
patterns and not all strains move on semi-solid surfaces (101, 131). Although the type of 
motility displayed by A. baumannii has not been fully elucidated, previous studies suggest 
that it may vary in response to illumination, quorum sensing or other factors (23, 104, 
131). 
 Type IV pili 
The type IV pili (TFP) are organelles with polymeric 
organization that extend several micrometres from the 
cell body (135). Due to their ability to assemble and 
disassemble rapidly, TFP participate in processes such 
as natural transformation, twitching motility, and 
adherence to abiotic and biotic surfaces (136). By 
cycles of polymerization, surfaces adhesion, and 
retraction, TFP pull the cell body along surfaces 
mediating twitching motility (Figure 3) (135). Thus, an 
insertion in pilT, coding for an ATPase required for the 
retraction of the TFP, impaired surface motility of A. 
nosocomialis strain M2 (131). Furthermore, pilA, pilD, 
and pilT mutants of this strain lost their ability to be 
naturally transformable and did not exhibit twitching 
motility (136). The major fimbrial subunit, PilA, is 
highly variable among A. baumannii strains and these 
differences are correlated with their motility abilities (100). 
 Lipopolysaccharide and exopolysaccharide 
Production of lipopolysaccharide and exopolysaccharide is required for motility in many 
Gram-negative bacteria. Mutations in genes involved in their synthesis may cause a 
decrease in motility (137-139). In A. baumannii 307-0294 strain the motility phenotype is 
affected by the activity of the glycosyltransferase LpsB (140), as well as by the protein 
tyrosine kinase PTK and the polysaccharide export outer membrane protein EpsA, 
Figure 3. The type IV pili pulls the 
cell body along surfaces by cycles of 
polymerization, surface adhesion, 
and retraction. Modified from Maier 
and Wong. 2015  (135). 
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required for capsule polymerization and assembly (141). Mutant strains harbouring 
transposon insertions in lpsB, epsA, and ptk resulted in a reduction in motility. These 
strains were capable of some motility but their movement was significantly diminished 
and the pattern varied from the wild type strain (142). Furthermore, the presence of 
Congo red in the medium, a dye that inhibits the production of exopolysaccharide, 
produced a wide variety of changes in motility of several A. baumannii strains (142). 
 Quorum sensing 
Several bacterial pathogens utilize quorum sensing cell communication to coordinate 
multiple virulence factors, such as motility, once a population size threshold is reached 
(143). Accordingly, the addition of a non-native AHL enhances twitching motility in A. 
baumannii ATCC 19606
T
 strain (128). Furthermore, the loss of the autoinducer synthase 
AbaI, present in different strains of A. baumannii and A. nosocomialis strain M2, cause 
decrease in motility and the phenotype is restored when exogenous AHL is added (131). 
The altered expression of genes regulated by the AbaI quorum-sensing pathway results 
also in deficiencies in the motility pattern. Insertions in genes A1S_0112, A1S_0113 and 
A1S_0115, which are up-regulated by quorum sensing, cause non-motile phenotypes 
(131, 132). 
The intercellular communication mediated by AHL requires protein receptors. This role 
seems to be played by AbaR in A. baumannii, a LuxR-type receptor that activates the 
transcription of QS target genes (144). Some non-native AHLs act as AbaR antagonists 
inhibiting A. baumannii motility (145). Furthermore, the presence of AidA, a hydrolase 
enzyme with quorum quenching activity, was recently related with a non-motile 
phenotype in several A. baumannii strains (146). 
 Environmental factors 
Motility is dependent upon different environmental signals that may vary its pattern 
(142). Light is a ubiquitous cue that may cause physiological changes in many organisms. 
Due to the production of light-sensing photoreceptors, different bacteria are able to detect 
and respond to light (104). Thereby, while A. baumannii ATCC 17978 cells grew only 
around the inoculation point in the presence of blue light, bacteria moved away from the 
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inoculation site covering almost half of the surface when motility plates were incubated in 
darkness (104). 
Motility phenotype is dependent upon the medium richness, and extracellular stressful 
conditions applied to the bacteria can alter them (142). Accordingly, the addition of a sub-
inhibitory concentration of antibiotics such as ampicillin and kanamycin or the 
disinfecting agent triclosan reduced the motility of different isolates of A. baumannii 
(142). Other stressful conditions, as an increased osmolarity or the addition of 1% ethanol 
reduced motility of all strains (142). 
 
1.2.3.3. Iron acquisition 
Competition for iron by potential pathogens is essential to establish an infection. 
Although iron is one of the most abundant elements in environmental and biological 
systems, ferric iron is not readily available for bacteria either in the environment or in the 
human host due to its low solubility under aerobic conditions and its chelation by 
compounds as heme, lactoferrin and transferrin (147). This micronutrient plays an 
essential role in diverse cellular processes such as electron transport, nucleic acid 
biosynthesis, and protection from free radicals (148).  
Bacteria can survive and divide under iron-limiting conditions by exploiting different 
strategies for high-affinity iron acquisition, including production of siderophores, ferric 
iron chelators that are released outside cells, uptake of exogenous chelators, as heme and 
heterologous siderophores, and acquisition of ferrous iron (102). Low free-iron 
concentration in host organisms is used by pathogens as a stimulus to express not only 
iron-acquisition systems, but genes coding for virulence factors, such as hemolysins, 
toxins and proteases (149). 
 Siderophores 
Siderophores are low molecular weight compounds with high affinity for iron. Once they 
are secreted from the cell and sequester ferric iron from the extracellular environment, 
siderophores are transported back into the cell through specific outer membrane receptors 
(150). The best-characterized siderophore in A. baumannii is acinetobactin, which was 
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initially described in the ATCC 19606
T
 strain (151, 152). Impairment of acinetobactin 
biosynthesis and transport in A. baumannii ATCC 19606
T
 affects the virulence of the 
strain, significantly reducing its ability to persist and kill the host in a G. mellonella 
larvae infection model (153). The expression of entA gene, which is essential for the 
biosynthesis of the acinetobactin precursor 2,3-dihydroxybenzoic acid, is also needed for 
the full virulence of the ATCC 19606
T
 strain (154). Furthermore, a study showed that 
acinetobactin production occurred significantly more frequently in clinical isolates 
compared with avirulent isolates of A. baumannii (155). 
Apart from acinetobactin, different gene clusters encoding siderophores, including cluster 
A1S_1647-1657, cluster A1S_2562-2581, cluster orn73-entD, and cluster ABAYE1888-
1889, have been described in several A. baumannii strains (156). Cluster A1S_1647-1657 
is as extended as acinetobactin among A. baumannii strains, being present in all genomes 
analysed except SDF. Cluster A1S_2562-2581 is found in A. baumannii ATCC 17978 
and A. baylyi ADP1 strains. Cluster orn73-entD seems to be present only in strain 8399, 
while cluster ABAYE1888-1889 was studied in all strains except in ATCC 17978 and 
ADP1 (156-158). 
 Other iron-uptake systems 
The production and secretion of siderophores is an energy intensive mechanism of iron 
uptake, but bacteria can adapt to iron limited environment through the expression of a 
range of iron acquisition mechanisms (156). A major route for bacterial iron assimilation 
is the direct uptake of ferrous iron by using the Feo system, which consists of the 
cytosolic FeoA protein, the inner membrane permease FeoB, and the putative 
transcriptional repressor FeoC (159). Sequenced genomes of A. baumannii showed the 
presence of genes encoding for a Feo transport system in these specie (160, 161). 
 A. baumannii also uses heme as an iron source since two clusters encoding functions 
related to heme uptake have been identified (160). The chromosomal cluster annotated as 
A1S_1608-1614 in ATCC 17978 could be involved in the transport of heme from the 
periplasm into the cytoplasm (23). Genes of this putative operon encode two heme-
binding protein A precursors and ABC-type transporter proteins that could be implicated 
in iron acquisition from heme (162). The second cluster, present in ACICU, AB0057 and 
SDF strains, includes an outer membrane receptor gene, the hemO gene involved in 
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oxidative cleavage of heme to release iron, as well as a tonB gene, which is part of a 
protein complex that mediates energy transduction from the inner to the outer membrane 
(160).  
 
1.2.3.4. Other virulence factors 
Multiple virulence factors that promote bacterial colonization and infection of the host are 
required for the pathogenesis of the bacteria (102). Despite extensive research into the 
virulence potential of A. baumannii, little is still known about its pathogenic repertoire. 
Although an increasing number of genomes have been sequenced and phenotypic analysis 
have allowed us to identify of several factors responsible of its pathogenicity, relatively 
few virulence factors have been described to date (147). 
Probably the best-characterized virulence factor of A. baumannii is OmpA (23). OmpA is 
a porin, an outer membrane protein responsible of modulating cellular permeability. As 
previously mentioned, this protein is not only involved in attachment to biotic and abiotic 
surfaces, but also in pathogenesis of this microorganism. Purified OmpA binds to host 
epithelial cells, targets mitochondria, and induces apoptosis (119, 122). The ompA gene 
was shown to be involved in persistence of A. baumannii in the lung, assessed using a 
murine pneumonia model (124), as well as in biofilm formation and surface motility, 
which highlights its role on the pathogenesis of A. baumannii (121, 131). 
The Omp33-36, which acts as a water passage channel, is also associated with A. 
baumannii cytotoxicity. Its deletion reduces adherence and invasion of human lung 
epithelial cells (163). Purified Omp33-36 induces apoptosis and modulates autophagy in 
human cells (164). Decreased expression of genes encoding the porins CarO and OprD-
like are also associated with attenuated virulence in a mouse model (165). 
The cellular envelope is associated with several factors that may contribute to 
pathogenicity in mammalian infection disease models (166). The production of capsular 
polysaccharides occurs in many isolates from patients with A. baumannii infections (167). 
Experiments with capsule-defective mutants have demonstrated the role of capsular 
exopolysaccharide of A. baumannii in virulence in a mouse septicaemia model as well as 
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in a rat soft tissue infection model (141, 168). Capsular polysaccharides are also involved 
in antimicrobial resistance as mutants have lower intrinsic resistance to peptide antibiotics 
(166). In addition, the presence of antibiotics induces hyperproduction of capsular 
polysaccharides which increases virulence in a mouse model of systemic infection (166). 
Lipopolysaccharide is the major component of the outer leaflet of the outer membrane 
and it is an immunostimulatory molecule that plays an important role in bacterial 
resistance to external stressful conditions (169). In A. baumannii, lipopolysaccharide 
plays a major role in virulence and survival of the bacteria as assessed by animal model 
experiments (147). Mutant cells with truncated lipopolysaccharide showed a decreased 
resistance to human serum and a reduced survival rate in a rat model of soft tissue 
infection (140). Furthermore, modification of lipopolysaccharide contributes to resistance 
to many clinical antibiotics, such as colistin (69). 
Some Gram-negative bacterial species secrete outer membrane vesicles (OMVs) during 
bacterial growth. OMVs are 20-200 nm diameter spherical vesicles that have been shown 
to participate in quorum sensing, biofilm formation, gene transfer, and transport of 
virulence factors (170, 171). Pathogen-host interactions may be mediated by OMVs 
through the delivery of diverse virulence factors to the interior of host cells, allowing the 
pathogens to interact with the host without a close contact (172). A study showed that an 
A. baumannii strain that produced abundant OMVs containing virulence factors was able 
to induce more cytotoxicity and stronger innate immune response in host cells (173). Due 
to the importance of OMVs in virulence, these structures have been used as candidates for 
acellular vaccines (171). 
Phospholipases (PLases) are lipolytic enzymes that catalyse the cleavage of phospholipids 
in bacterial membranes and are considered virulence factors in many bacteria. 
Degradation of phospholipids affects the stability of host cell membranes, and may 
interfere in the host immune response (174). According to the cleavage site on their 
substrate, PLases are classified into different groups: carboxyl ester acyl hydrolases, 
PLases C, and PLases D. Carboxyl ester acyl hydrolases include PLase A, PLaseB and 
lysophospholipase A (174). PLases C and D have been described in several pathogenic 
bacteria, playing a role in virulence (175, 176). Disruption of A. baumannii PLase D 
causes a reduction in its ability to thrive in serum, a deficiency in epithelial cell invasion, 
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and diminished pathogenesis in a murine model of pneumonia (177). Accordingly, the 
inactivation of a PLase C gene causes a modest decrease in the cytotoxic effect caused by 
A. baumannii on epithelial cells (178). 
PBPs are commonly involved in resistance to β-lactam antibiotics. However, PBPs 
contribute to bacterial cell stability by participating in the biosynthesis of the 
peptidoglycan layer (23). PBPs are usually classified into high-molecular-mass and low-
molecular mass. High-molecular-mass PBPs enable peptidoglycan polymerization and 
insertion into the cell wall (179). Low-molecular-mass PBPs, such as PBPs 7 and 8, 
contribute to cell separation and peptidoglycan remodelling (180). The inactivation of 
PBPs 7 and 8 caused a significant decrease in the survival of the A. baumannii mutant 
strain in rats’ soft tissue and pneumonia infection models (181). β-Lactamase PER-1 has 
also been suggested to be a virulence factor as several PER-1-producing strains adhered 
to eukaryotic cells while all PER-1-negative strains showed a lack in cell adhesion (182). 
 
1.2.4. Animal models 
Animal models are a necessary tool in order to evaluate novel treatments, characterize the 
host immune response, and identify bacterial virulence factors. The first report describing 
an animal model for A. baumannii infection was published in 1997 (183). Since then, the 
development of new animal models allowed an increase of information available about A. 
baumannii pathogenesis (23). The use of animal models allows researchers to investigate 
human diseases resembling the progression of the infection as occurs in human patients. 
However, it is utopic to hope that laboratory animals can truly reproduce human diseases. 
Performing animal models requires complex facilities to maintain and handle large 
number of animals, thus non-mammalian models have emerged recently as useful tools to 
study microbial pathogenesis (81). Many research teams all over the globe have been 
implementing a simple model system for the host-pathogen interaction assays. 
Accordingly, invertebrate models have become popular as they are less expensive, less 
ethically challenging, and more efficient, as well as they allow the assessment of a larger 
number of bacterial mutant strains than the common murine models in the same 
experiment (184). The most commonly used invertebrate models include the 
Introduction 
 
48 
 
Caenorhabditis elegans worm model, the Drosophila melanogaster fly model, the G. 
mellonella caterpillar model, and the Dictyostelium discoideum amoebic model (81). The 
identification of virulence determinants in a wide range of human pathogenic bacteria 
have been described through the use of these models worldwide (185). 
Non-mammalian models have been used to study A. baumannii pathogenesis since 2004, 
when a C. elegans killing assay was implemented to measure survival of worms after 
exposure to this pathogen with and without ethanol (85). Following this work, C. elegans 
and D. discoideum were used to screen an A. baumannii transposon-generated library for 
isolating mutants with attenuated virulence in presence of ethanol (162). Instead of using 
a killing assay, mutants of this study were tested for the reduction of brood size in C. 
elegans and the inhibition of D. discoideum. A recent study from Vallejo et al. (186) 
showed that the C. elegans fertility model was able to detect virulence differences 
between several A. baumannii strains and the results obtained were validated in a murine 
sepsis model. Furthermore, C. elegans models have been performed not only to examine 
the virulence features of different A. baumannii strains (187-189), but also to study the 
interaction between this pathogen and C. albicans. Therefore, this model can be used to 
investigate the complex dynamics of a polymicrobial infection (190). 
G. mellonella, the larval stage of the wax moth, has also been used as model for infection 
caused by A. baumannii (25). In this model, caterpillars are infected by injecting the 
pathogen into the hemocel of the animal. Peleg et al. showed that the rate of G. 
mellonella killing was dependent on the infection inoculum and on the virulence of the 
strains injected. Furthermore, treatment of lethal A. baumannii infection with proper 
antibiotics prolonged the survival of G. mellonella caterpillars (25). This model has been 
used to evaluate the in vivo efficacy of different treatments against multidrug-resistant A. 
baumannii strains (191, 192). Different proteins that play a role in pathogenesis have also 
been identified using G. mellonella models, such as the acinetobactin-mediated iron 
acquisition system or the proteins involved in the synthesis of 1,3-diaminopropane or 
phospholipase D (153, 193, 194). 
Despite the advantages of non-mammalian models, mammalian infection model systems 
remain the gold standard for pathogenesis-based research. Mammalian models of A. 
baumannii infection allow the characterization of a host response similar to that found in 
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human infections and permit the study of antibiotic regimens for the treatment of 
infections (23).  
Due to the low virulence of most A. baumannii strains in mice, high infection doses are 
required to establish infection. Alternatively, several studies have employed 
immunocompromised mice to facilitate infection or porcine mucin mixed in the 
inoculum, as it protects bacteria from rapid innate immune clearance (23). Although, 
these models may mask host-microbe interactions that are important in determining host 
outcome, they likely expose virulence functions that become relevant in the context of an 
infection (195). 
Lung infection models in small rodents, produced by either intratracheal or intranasal 
inoculation, have been thoroughly reported in A. baumannii since this pathogen mainly 
causes pneumonia (81). Earlier mouse models of pneumonia were performed to test the 
pharmacodynamics properties of various antibiotics where animals were infected through 
intratracheal instillation (183, 196). One of the first studies using intranasal inoculation in 
a murine pneumonia model was carried out to identify the importance of the 
lipopolysaccharide-induced inflammatory response to A. baumannii infection (197). 
The pneumonia model has also been employed for characterizing virulence factors 
involved in respiratory infections. Thus, the role of OmpA on A. baumannii pathogenesis 
was determined infecting C57BL/6 mice intratracheally in order to perform an 
experimental pneumonia model. The bacterial burden in mice infected with an OmpA 
defective strain was significantly lower than in those infected with the wild type strain 
(120). Even though the most of the animal models have employed mice, models using 
other species have also been implemented. Hraiech et al. compared the fitness and lung 
pathogenicity of two isogenic A. baumannii strains in a rat model of pneumonia, 
concluding that mutations in the pmrA gene, related to colistin resistance, lead to a 
reduced virulence (198). 
Animal models for studying soft tissue infection by A. baumannii have also been 
performed. Rat soft tissue infection has proved to be an efficient model to discriminate 
among the differences in virulence abilities of various A. baumannii isolates (199). The 
utilization of mutant strains for challenge in this type of infection model allowed the 
identification of genes essential for growth in vivo (199). Above mentioned studies 
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performing rat soft tissue infections demonstrated that a capsule-positive phenotype and 
an integral lipopolysaccharide are important for in vivo survival of A. baumannii (140, 
141). 
Models of A. baumannii causing sepsis have also been reported recently. Although the 
source of infection, usually intraperitoneal instillation, is an important difference between 
this model and the human disease process, this model has been extensively performed due 
to its easy inoculation, high mortality, and the possibility of measuring bacterial loads in 
multiple organs (23). Several A. baumannii virulence factors, such as the acinetobactin, 
the Omp33-36 or the autotransporter Ata, have been identified through intraperitoneal 
mouse sepsis models (114, 153, 163). Mouse septicemia models have also been employed 
to characterize the efficacy of vaccines and to evaluate the effect of antibiotic resistance 
on virulence and fitness (200, 201). 
 
 
1.3. Small RNAs in bacteria 
Bacteria have specific regulatory molecules for controlling gene expression. RNAs 
transcripts are well-known regulators and their roles cannot be ignored in any organism. 
In bacteria, an important number of these RNA regulators exist as short transcripts (50-
300 nucleotides) that act on independently expressed targets and that are commonly 
referred to as small RNAs (sRNAs) (202). Regulatory RNAs can modulate transcription, 
translation, mRNA stability, and DNA maintenance or silencing through a variety of 
mechanisms, such as changes in RNA conformation, protein binding, base pairing with 
other RNAs, or interactions with DNA (203). 
First sRNA was discovered in 1981. It was 108 nucleotide long, named as RNA I, that 
blocked ColE1 plasmid replication by base pairing with the RNA that is cleaved to 
produce the replication primer (204). This sRNA and some others were identified by gel 
analysis due to their abundance or simply by chance (203). Since 2001, new sRNAs have 
been discovered by systematic computational searches or by direct detection using 
cloning-based techniques or microarrays using probes in intergenic regions (205, 206). 
The availability of bacterial genome sequences have led to the identification of an 
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increasing number of regulatory RNAs. Recent technical advances, including 
multilayered computational searches and deep sequencing, have allowed the prediction of 
hundreds of candidate regulatory RNAs (207, 208). 
Riboswitches, the simplest bacterial RNA regulatory elements, are defined as sequences 
found at the 5’ end region of mRNA, or less frequently at the 3’ end region, that adopt 
different conformations in response to environmental signals that act as ligands (209). 
They usually consists of two parts: the aptamer region, which binds the ligand, and the 
expression platform, which regulates gene expression through alternative RNA structures 
that affect transcription or translation (210). Upon binding of the ligand, the riboswitch 
changes conformation, creating alternative hairpin structures which form or disrupt 
transcriptional terminators or antiterminators, or which occlude or expose ribosome 
binding sites (203). Generally, the riboswitches in Gram-positive bacteria affect 
transcriptional attenuation, while more frequently inhibit translation in Gram-negative 
(211). 
Some sRNAs interact with proteins regulating their activity by sequestering them from 
normal targets, particularly RNA binding proteins, or producing more complex outcomes, 
as the modification of an enzymatic activity (202). Small RNAs that regulate RNA 
binding proteins typically work by mimicry, since those sRNAs contain the protein 
recognition sequence. Noted examples are CsrB and CsrC sRNAs of Escherichia coli, 
which modulate the activity of CsrA, an RNA-binding protein that regulates mRNA 
translation and stability (212). Other sRNAs bind proteins with enzymatic activity, 
inhibiting, activating or modifying their function, such as the E. coli 6S RNA, which 
binds to the housekeeping form of RNA polymerase regulating transcription (213). 
Most characterized sRNAs regulate gene expression by base pairing with mRNAs. Some 
of them, known as cis-encoded sRNAs, have extensive potential for base pairing with 
their target mRNA while trans-encoded sRNAs have more limited complementarity with 
their targets (203). The first group is encoded in cis on the DNA strand opposite the target 
RNA and share extended regions of complete complementarity with their target. 
Regulatory mechanisms employed by these sRNAs encompass transcriptional 
attenuation, inhibition of translation or promotion of RNA degradation or cleavage 
(Figure 4) (214). 
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Figure 4. Cis-encoded sRNAs. Modified form Waters and Storz. 2009 (203). 
Early identified cis-encoded antisense RNAs were found opposite to replication genes of 
plasmids or to transposase genes, controlling maintenance and stability of mobile genetic 
elements (215). Many of these sRNAs are components of type I toxin-antitoxin systems. 
These two-gene elements consist of a stable toxin and an unstable cis-encoded RNA 
antitoxin that base pairs with the toxin mRNA, inhibiting its translation and leading to 
degradation (216). 
Trans-encoded sRNAs consist on a diverse family of short, usually untranslated, 
transcripts that share only limited complementarity with their target mRNAs regulating 
their translation and/or stability (203). Most of them are global regulators of gene 
expression and are often induced in response to stress or inside of host cells (217). In 
contrast to cis-encoded sRNAs, each trans-encoded sRNA typically base pairs with 
multiple mRNAs. Thus, a single sRNA may globally modulate a particular physiological 
response, in the same manner as a transcription factor does, but at a post-transcriptional 
level (203). 
The majority of the regulation mediated by trans-encoded sRNAs blocks gene expression. 
Base pairing between the sRNA and its target mRNA usually leads to repression of 
protein levels through translational inhibition, mRNA degradation, or both (Figure 5) 
(218). However, sRNAs can also activate expression of their target through an anti-
antisense mechanism whereby base pairing of the sRNA disrupts an inhibitory secondary 
structure which sequesters the ribosome binding site (RBS) (219). In many cases, the 
RNA chaperone Hfq is required for trans-encoded sRNA-mediated regulation, 
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presumably to facilitate RNA-RNA interactions due to the limited complementarity 
between the sRNA and the mRNA target (203). 
 
Figure 5. Trans-encoded sRNAs. Modified from Waters and Storz. 2009 (203). 
Recently, an adaptive microbial immune system named Clustered Regularly Interspaced 
Short Palindromic Repeats (CRISPR), has been identified and provides resistance to 
viruses as well as prevent plasmid conjugation in bacteria and Archaea (220). Immunity is 
acquired by integrating short fragments of foreign DNA into CRISPR loci. Following 
transcription and processing of these loci, the CRISPR RNAs guide the CRISPR-
associated (Cas) proteins to invading complementary nucleic acid, which results in target 
interference (221). 
CRISPR-Cas systems are highly diverse, which is probably a result of the dynamic 
selective pressure that is imposed by invading mobile genetic elements (221). CRISPR 
sequences are variable DNA regions which consist of a ~550 bp leader sequence followed 
by series of repeat-spacer units (222). Spacer regions contain sequence homologous not 
only to foreign DNA but also to endogenous chromosomal regions of the bacteria. This 
self-targeting was proposed to lead to a form of autoimmunity, suggesting a role in 
regulation of endogenous gene expression (223). Adjacent to the CRISPR DNA array are 
several Cas genes. Two to six core Cas genes seem to be associated with most CRISPR 
systems (222). 
Introduction 
 
54 
 
The functionality and the role of CRISPR-Cas system are not fully established. It may 
promote bacterial fitness through protection against bacteriophages increase indirectly the 
survival rate and the ability to infect host cells. Alternatively, CRISPR-Cas system might 
have a direct influence by regulating endogenous virulence factors (224). 
 
1.3.1. Regulatory roles of small RNAs 
Bacteria live in between markedly different environments, which require detection, 
integration, and response to different conditions and subsequent realignment of the 
bacterial physiology and metabolism. Signals detected include changes in temperature, 
nutrient availability, or cues from the host and neighbouring bacteria (215). Gene 
expression is regulated at many different levels, beyond transcriptional control at the 
DNA level. Regulatory RNAs are recognized as important factors in many physiological 
and adaptive responses in bacteria (225). Some of them have been identified as previous 
missing links in the regulatory pathways that allow bacteria to sense population density, 
to modulate and to modify cell-surface properties, to fine-tune their metabolism during 
cell growth, and to regulate virulence gene expression (226). 
 
1.3.1.1. Role of small RNAs in biofilm formation 
Biofilm structure protects bacteria from a damaging environment. Biofilm formation is 
one of the most complex physiological processes in bacteria. Thus, the decision-making 
process of bacteria to form biofilm or not should be precisely and dynamically regulated 
in response to environmental changes (227). Although transcriptional regulation is the 
most well studied form of controlling biofilm production, post-transcriptional regulation 
allows bacteria to rapidly adjust to the changing environment. Post-transcriptional 
regulatory mechanisms monitoring biofilm formation include RNA-binding proteins and 
cis- and trans-acting small RNAs (93). 
The c-di-GMP RNA is implicated in controlling several cellular functions including 
virulence, motility, and adhesion, but its principal role consists on modulating the switch 
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that controls the transformation from motile planktonic lifestyle to the sessile biofilm 
state (228). High c-di-GMP levels promote the synthesis of exopolysaccharides, as well 
as the auto-aggregation and the surface adhesion, which locks the cells in a sessile state. 
In contrast, low c-di-GMP concentrations inhibit biofilm formation and the production of 
adhesive surface organelles, stimulating swimming and swarming motility (229). 
One of the best characterized regulatory elements is CsgD, the global transcription factor 
that integrates signals to control biofilm formation in E. coli and Salmonella (93). CsgD 
induces the expression of the csgBAC operon, required for the production of curli 
fimbriae and cellulose, two factors needed for biofilm formation, as well as the 
production of c-di-GMP or the repression of flagellar operons favouring the biofilm-
formation phenotype (230). CsgD can be repressed by several sRNAs, such as OmrA, 
OmrB, GcvB, McaS, and RprA, that respond to various stress conditions (231). The non-
coding RNA McaS disfavours biofilm formation by binding and exerting inverse control 
on csgD and the flhCD operon, the master regulator of flagella expression in E. coli and 
related bacteria (232). In the absence of McaS, csgD upregulation occurs and an increased 
McaS expression activates the synthesis of flhDC (232, 233). However, the McaS-
dependent regulation of biofilm seems to be complex, and also activates PNGA leading to 
a CsgD independent pathway of biofilm formation (233). 
RpoS, the general stress response sigma factor, is activated by the sRNA RprA, which 
targets several branches of the CsgD network in response to environmental cues (234). 
Cell transition into stationary phase activates RprA and subsequently csgD expression 
and curli biosynthesis (234). The non-coding RNAs OmrA and OmrB are induced during 
high osmolarity conditions and their over-expression inhibits curli and cellulose 
production (235). 
Although most regulatory RNAs directly interact with mRNA targets, this is not the only 
mode of action of sRNAs. The above mentioned small RNAs CsrB and CsrC interact 
with the protein CsrA and prevent the latter from binding to several biofilm-relevant 
mRNAs (236). Cells entering into stationary phase induce CsrB and CsrC, which 
sequester and inactivate CsrA. This fact switches from the production of flagella to the 
synthesis of the biofilm matrix component PNAG (237). 
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As described above, biofilm formation and development is an intricate process involving 
finely altered gene expression, requiring complex and well-coordinated regulation. Small 
RNAs can contribute to post-transcriptional regulation and make to rapidly adjust and 
fine-tune gene expression required for the cell during biofilm formation (93).  
 
1.3.1.2. Role of small RNAs in metabolism 
Changes in nutrient abundance trigger major switches in gene expression and require 
coordination of global regulatory networks. These calculations that depend on the kind 
and amount of nutrients usually implicate transcriptional regulators and RNA regulators 
(238). One of them is the previously mentioned Csr (carbon storage regulatory) system, 
which ensures connections between carbon metabolism and other traits in many bacteria. 
In E. coli, CsrA is the repressor that regulates carbon starvation and glycogen 
biosynthesis, biofilm formation, motility, virulence, quorum sensing, and stress response 
system by binding to conserved sequences in its target mRNA that alter their translation 
and/or turnover (237). The sRNAs CsrB and CsrC, antagonize its activity during the 
exponential growth phase and repress metabolic pathways related to the stationary phase 
(212). 
Amino acids may also be used as energy sources by bacteria and the regulation of their 
catabolism may involve sRNA. In Bacillus subtilis, the sRNA Sr1 controls AhrC, a 
transcriptional activator of rocABC and rocDEF (239). These operons encode catabolic 
and transport enzymes required for the use of arginine. Sr1 transcription is stimulated by 
the presence of L-arginine or stationary-phase entrance and it is repressed when sugars 
are used as the energy source (240).  The sRNA GcvB is also involved in the regulation 
of amino acid catabolism. It is induced by high concentrations of glycine and regulates 
oppA and dppA mRNAs, which encode oligopeptide and dipeptide periplasmic binding 
proteins, respectively (241).  
As a nutrient, iron is required for the operation of many important enzymes in central 
metabolism, as well as synthesis processes. The sRNA RyhB of E. coli is a key regulator 
of iron homeostasis that modulates cellular physiology under iron-starvation conditions 
by regulating a large set of genes that primarily encode iron-containing enzymes (242). 
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sRNAs with similar functions have been identified in different Gram-negative species, 
such as PrrF1 and PrrF2 of P. aeruginosa (238). In E. coli and P. aeruginosa, the 
production of sRNA associated with iron assimilation is regulated by the Fur repressor 
(243).  
 
1.3.1.3. Role of small RNAs in virulence 
Pathogenic bacteria possess intricate regulatory networks that temporally control the 
production of virulence factors, and enable bacteria to survive and proliferate after host 
infection. Regulatory RNAs are now recognized as important components of these 
networks (226). Small RNAs have an impact on bacteria pathogenicity as they participate 
in regulation of biofilm formation, motility, and cellular metabolism. Moreover, several 
sRNAs have been identified as regulators of different virulence factors (238). 
Vibrio cholerae pathogenicity as well as its life cycle are considered well studied models 
for the understanding of molecular processes involving virulence gene expression. Two 
sRNAs regulators that affect pathogenicity of V. cholerae are TarA and TarB, both of 
which are controlled by the master virulence regulator ToxT (226). TarA negatively 
regulates the major glucose transporter PtsG (244), whereas TarB down-regulates the 
secreted colonization factor TcpF and the transcription regulator VspR (245, 246). VspR 
modulates the expression of several genes, including dncV, which encodes a di-nucleotide 
cyclase and is required for efficient intestinal colonization (246). A mutant strain lacking 
TarA is compromise for mouse colonization in competition with wild type, suggesting its 
role in the in vivo fitness showed by V. cholerae (244). However, the tarB knockout strain 
outcompetes the parental strain, indicating that TarB is a negative regulator of virulence 
of V. cholerae (245). 
The expression of a variety of genes that play an important role in the virulence and 
survival of P. aeruginosa is affected by the sRNAs RsmY and RsmZ, analogous to E. coli 
CsrB and CsrC, which act sequestering the transcriptional regulator RsmA (247). RsmA 
controls the switch between acute and chronic infection through the regulation of motility 
and biofilm (248). 
Introduction 
 
58 
 
These and many other examples indicate that sRNAs are required for a coordinated 
response and play a crucial role in virulence. Despite the increasing number of identified 
sRNAs, only a few of them have been functionally characterized (238). Thus, further 
studies are required in order to fully decipher the role that regulatory RNAs play in 
pathogenicity. 
 
1.3.1.4. Role of small RNAs in antibiotic resistance 
Traditionally, efforts to find novel therapeutic treatment options have been focussed on 
bacterial proteins as drug targets. However, regulatory RNAs have proven to be important 
factors for the bacterial response and resistance to antibiotics (249). Mechanisms 
controlling antibiotic resistance genes at the post-transcriptional level generates an 
immediate response, which is beneficial when antibiotic concentrations increase rapidly 
(249). sRNAs play a key role in regulatory circuits controlling antibiotic resistance 
through various processes, including antibiotic uptake, modifications of the cell envelope, 
drug efflux pumps, and DNA mutagenesis mechanisms that facilitate the emergence of 
novel mechanisms of resistance (250-253). 
Antimicrobial resistance in E. coli is modulated by the sRNAs MicF, GcvB, and RyhB, 
which regulate genes required for antibiotic uptake. MicF represses translation of the 
porin OmpF, a major antibiotics uptake pathway. Deletion of micF gene increases the 
susceptibility to cephalosporins and norfloxacin whereas its over-expression increases the 
resistance of E. coli against these antibiotics (250). GcvB represses the mRNA of the 
serine transporter CycA and the iron-responsive sRNA RyhB sensitizes E. coli to colicin 
Ia (254). 
Several sRNAs regulate genes coding for drug efflux pumps, active transporters that 
pump toxic substances, including antibiotics, out of the cell. The AcrAB-TolC multidrug 
efflux pump is negatively regulated by the sRNA SdsR. This sRNA binds and represses 
the tolC mRNA, which encodes the porin of AcrAB system, preventing the efflux of 
lipophilic antibiotics (252). Thus, over-expression of SdsR reduces resistance to 
novobiocin and several quinolone antibiotics (250, 252).  
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Recently, a library of E. coli strains overproducing and lacking sRNAs was screened for 
altered susceptibility to various antibiotics. Over-expression of 17 out of 26 sRNAs 
affected resistance or susceptibility to antibiotics suggesting that sRNAs are important 
elements in controlling antibiotic resistance genes (250). 
 
1.3.2. Small RNAs in A. baumannii 
Small RNAs have proved to be a class of gene regulators of several cellular processes in 
bacteria. Although expression patterns and regulatory mechanisms employed by sRNAs 
are well understood in Enterobacteriaceae such as E. coli or Salmonella (255, 256), 
researchers are still not able to confirm whether sRNA-mediated regulation in A. 
baumannii is analogous to these well-studied systems (257). 
The first study reporting sRNAs in A. baumannii was performed by Sharma et al. (258), 
wherein a total of 31 putative sRNA were predicted by a bioinformatic approach. Three 
of them, named AbsR11, AbsR25 and AbsR28, were detected by Northern blot and did 
not show similarity with previously described sRNAs. Differential expression profile of 
AbsR25 in presence of varying amounts of ethidium bromide suggested an expression 
influenced by environmental or internal signals. 
Recently, Weiss et al. have identified 78 sRNAs in the A. baumannii AB5075 strain 
based on RNA sequencing (RNA-seq) results (259). Using conservation analysis six types 
of similar sRNAs were identified, with one found to be particularly abundant and 
homologous to regulatory C4 antisense RNAs found in bacteriophages. Additionally, two 
sRNAs were found to be antisense to phage-derived transcripts, giving them the potential 
to exert broad regulatory influence. 
Only the sRNA Aar has been studied as a regulatory RNA in A. baylyi. Over-expression 
of Aar in trans did not affect bacterial growth but seven mRNA targets were upregulated 
in stationary growth phase. All those seven mRNAs were shown to be involved in A. 
baylyi amino acid metabolism (260). This sRNA is conserved in A. baumannii, as Aar 
homologs were found in A. baumannii strains SDF, AB307-00294, AB5075, ACICU, 
AYE, and ATCC 17978  (259, 260). 
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The role of the RNA chaperone Hfq, involved in the regulation of diverse genes via 
sRNAs, has been studied in A. baumannii ATCC 17978 (261). In the absence of the hfq 
gene, the mutant strain exhibited retarded cell growth and reduced biofilm formation, 
airway epithelial cell adhesion and invasion, and survival in macrophage. The loss of hfq 
gene also caused a decrease in outer membrane vesicles secretion and fimbriae production 
and affected transcription of genes involved in stress response. Taken together, these data 
indicate that Hfq plays a critical role in environmental adaptation and virulence in A. 
baumannii by modulating stress response and virulence factors (261). 
So far, very few regulatory RNAs have been defined in A. baumannii and the mechanisms 
of RNA-mediated gene regulation remain unknown. Thus, multiple efforts are required to 
understand how genes are regulated by sRNAs in this pathogen. 
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A. baumannii is one of the most important pathogens that cause hospital infections and 
constitutes a remarkable public health problem due to its ability to develop antibiotic 
resistance and to adapt to stressful conditions. The capacity of A. baumannii to form 
biofilm allows its resistance to desiccation, to antimicrobial agents, and to survive to the 
host immune system. The understanding of the different steps that regulate A. baumannii 
biofilm formation may offer the key to explain its virulence mechanisms. 
Thus, the objectives of the present study were the following: 
1. The study of the gene expression patterns of A. baumannii planktonic and sessile 
cells. 
2. The identification of genes involved in biofilm formation in A. baumannii. 
3. The characterization of the A1S_0114 gene and the study of its role in different 
biological processes including attachment to eukaryotic cells, virulence, and 
biosynthesis of metabolites. 
4. The description of sRNAs in A. baumannii and the comparison of their expression 
in different lifestyles, including biofilm. 
5. The description of sRNAs implicated in biofilm regulation. 
6. The study of the role of the 13573 sRNA in biofilm formation and attachment. 
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3.1. CHAPTER I: Whole transcriptome analysis of Acinetobacter 
baumannii assessed by RNA-sequencing reveals different mRNA 
expression profiles in biofilm compared to planktonic cells 
 
A. baumannii has become an important opportunistic pathogen because of its genetic 
plasticity, which enables its adaptation to stressful conditions and to develop antibiotic 
resistance. Furthermore, the A. baumannii ability to colonize both biotic and abiotic 
surfaces and to grow in a sessile lifestyle plays an important role in the capacity of the 
microorganism to persist and spread in the hospital environment.  A deep understanding 
of the mechanisms that promote biofilm formation is essential to identify new therapeutic 
targets. Thus, transcriptome sequencing is a goal tool to gain insight into the differences 
in genes expressed under diverse conditions. 
This chapter is focused on a transcriptome analysis performed over different A. 
baumannii ATCC 17978 lifestyles. Transcripts from sessile biofilm cells, as well as 
planktonic cells from exponential and stationary phase, were analysed by Illumina RNA-
seq in order to recognise distinct expression patterns and to detect genes that were 
differentially expressed.  
Although many genes were constitutively expressed, results showed clearly particular 
patterns in biofilm and in planktonic cells. A total of 1621 genes were over-expressed in 
biofilm compared to planktonic cells and 55 genes were exclusively expressed in sessile 
cells. Some of these genes were involved in transcriptional regulation, amino acid 
metabolism and transport, and iron acquisition. Genes encoding efflux pumps, a fimbrial 
protein, Csu proteins or an acyl carrier protein were also detected. 
Five genes encoding an acyl carrier protein (ACP) (A1S_0114), a hypothetical protein 
(A1S_0302), a fimbrial protein (A1S_1507), a pilus assembly protein (A1S_3168), and a 
transcriptional regulator (A1S_2042) have been demonstrated to play a role in biofilm 
formation as their disruption caused a decrease in this capacity of the mutant strains 
compared to the wild type ATCC 17978 strain. 
The gene A1S_0114 was deleted from the genome to obtain a stable mutant (Δ0114). 
This knockout strain produced significantly less biofilm than the wild type strain. The 
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role of the A1S_0114 gene in the ability of A. baumannii to form biofilm was confirmed 
and the mutant strain was complemented with a plasmid harbouring A1S_0114 gene, 
restoring the wild type phenotype. The loss of the A1S_0114 gene caused a reduction of 
the expression level of the surrounding genes A1S_0109, A1S_0112, and A1S_0113 
during the stationary phase of growth. Since A1S_0109 encodes the only homoserine 
lactone synthase described to date in A. baumannii, these results also confirmed that 
quorum sensing plays a role in biofilm formation. Moreover, the A1S_0112-0118 cluster 
of genes could constitute an operon involved in biofilm formation and quorum sensing as 
all these genes are over-expressed in biofilm-associated cells compared to planktonic 
cells. 
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3.2. CHAPTER II: Contribution of the A. baumannii A1S_0114 gene to 
the interaction with eukaryotic cells and virulence 
 
The previous transcriptomic analysis described in chapter I allowed us to identify and 
characterize the A1S_0114 gene of A. baumannii ATCC 17978 as a key factor involved 
in biofilm formation, due to its high expression level in biofilm-associated cells compared 
to planktonic cells. Furthermore, several genes from the A1S_0112-A1S_0119 cluster 
which expression is activated through a quorum sensing pathway, have been shown to be 
involved in biofilm biogenesis and surface motility. This gene cluster was predicted to act 
as a non-ribosomal peptide synthase (NRPS) and to participate in the biosynthesis of an 
uncharacterized secondary metabolite. 
Thus, the aim of this chapter was to deepen the role of the A1S_0114 gene in different 
biological processes such as attachment to eukaryotic cells, virulence or synthesis of 
metabolites as well as decipher the relationship with its neighbouring genes. Firstly, in 
silico analysis of the region containing A1S_0112 to A1S_0119 genes indicated that they 
could form a polycistronic operon. RT-PCR assays confirmed these results and a review 
of their functions suggested that they could be involved in the production of secondary 
metabolites. 
The implication of the A1S_0114 gene in biofilm formation was confirmed by scanning 
electron microscopy (SEM). SEM Images showed that the ATCC 17978 cells attached 
and formed multicellular structures on abiotic surfaces unlike the A1S_0114 defective 
strain, which was unable to form three-dimensional structures. 
Adhesion experiments to A459 human epithelial alveolar cells were also performed. 
Adherence of the strain lacking the A1S_0114 gene was significantly lower than the wild 
type strain. Complementation of the knockout strain resulted in a restored attachment 
ability. SEM images supported these observations since while the ATCC 17978 strain 
could damage the surfactant layer and many bacteria were adhered to eukaryotic cells, 
only a few mutant cells were observed in the case of the defective strains lacking the 
A1S_0114 gene. These data suggest that the A1S_0114 gene plays an important role not 
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only in attachment to abiotic surfaces but also in adhesion to eukaryotic cells, which 
remarks its potential role in pathogenesis. 
Thus, the role of the A1S_0114 gene in virulence was tested through three different 
animal models. A C. elegans fertility assay showed that the number of viable eggs was 
almost twice higher in worms infected with the knockout mutant strain compared to those 
infected with the wild type. Similar results were observed using a G. mellonella killing 
assay. A higher survival rate was obtained when larvae were infected with the mutant 
strain. The murine pneumonia model showed that lungs from mice infected with the 
mutant strain had a lower bacterial burden than those infected with the ATCC 17978 
strain, which confirms and extends the previous results demonstrating the role of the 
A1S_0114 gene in virulence. 
A liquid chromatography/mass spectrometry (LQ/MS) analysis of culture supernatants 
allowed us to detect the presence of a 505.28 Da molecule, named as acinetin 505 (Ac-
505), that was present in the ATCC 17978 strain and absent in samples from the knockout 
strain. Ac-505 (C23H43N3O7) resembles a three-amino acid lipopeptide with non-standard 
linkages between amino acids as well as to the hydrocarbon moiety. 
Altogether, data support the implication of the A1S_0114 gene of A. baumannii in 
virulence and suggest its involvement in the biosynthesis of the Ac-505 metabolite. 
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3.3. CHAPTER III: Global assessment of small RNAs reveals a non-
coding transcript involved in biofilm formation and attachment in 
Acinetobacter baumannii ATCC 17978 
 
Small non-coding RNAs regulate a wide range of functions and modulate many aspects 
of cellular metabolisms in bacteria. RNA regulators, acting at the post-transcriptional 
level, are less costly and faster to produce. However, little is known about the 
involvement of sRNAs in controlling biofilm formation and only a few have been 
described in A. baumannii. 
The objective of this chapter is to characterize the small RNA transcriptome of A. 
baumannii ATCC 17978 and to compare the expression of these sRNAs in both 
planktonic and biofilm-associated cells with the aim of finding possible candidates 
involved in biofilm formation. For this purpose, high throughput RNA sequencing was 
performed for exponential and stationary growth phase cells as well as for biofilm 
associated cells. 
A total of 255 putative sRNAs were selected as differently expressed in some of the three 
growing conditions. All detected sRNAs were located in the chromosome except sRNA 
29, which was located on plasmid pAB2. From them, a total of 185 putative sRNAs were 
differentially expressed in biofilm or stationary phase compared to exponential phase. In 
biofilm cells, 28 putative sRNAs were up-regulated and 32 down-regulated with respect 
to planktonic cells. One of these sRNAs, the 13573 sRNA, showed a 120-fold over-
expression in biofilm cells with respect to planktonic cells. Moreover, 9 sRNAs were 
exclusively detected in biofilm cells and 21 were only present in planktonic cells. Deep 
sequencing results were corroborated using RT-qPCR procedures for six sRNAs only 
expressed in biofilm and the 13573 sRNA. 
The high level of expression of the 13573 sRNA in biofilm-associated cells suggested its 
potential role in biofilm regulation. A knockout mutant strain (Δ13573), as well as a 
strain over-expressing the 13573 sRNA (13573), were constructed in order to elucidate its 
role in pathogenesis. Repression and over-expression of the 13573 sRNA in their 
respective strains were confirmed by RT-qPCR using Taqman probes. 
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Biofilm assays showed that the lack of the 13573 sRNA caused a slight but non-
significant reduction on biofilm production. However, the over-expression of 13573 
resulted in a 2-fold increase of biofilm formation compared to the wild type strain. SEM 
imaging revealed that the 13573 sRNA over-expressing cells develop tridimensional 
biofilm structures unlike the ATCC 17978 strain, which was not able to build such 
structures. The knockout strain cells showed a more disorganized pattern than cells from 
the parental strain. 
Adhesion to eukaryotic cells experiments indicated that the 13573 over-expressing strain 
attached to A549 alveolar cells 30 fold more than the wild type strain. Adhesion ability 
decreased in the 13573 knockout strain, but this effect was restored in the complemented 
strain, which reached higher values than the ATCC 17978 strain. SEM analysis of 
polarized human cells infected with the different strains revealed that the over-expression 
of the 13573 sRNA allowed bacteria to form tridimensional biofilm over the epithelial 
cells. As expected, the knockout strain showed a reduced adherence to eukaryotic cells 
compared to the wild type strain. 
Overall data indicated that the analysis of the sRNA transcriptome showed different 
patterns in biofilm-associated cells compared to both exponential and stationary phase 
cells. This analysis highlighted the presence of a remarkably over-expressed sRNA, 
named as 13573, in biofilm-associated cells. Phenotypic characterization of the 13573 
sRNA revealed its role in biofilm formation and attachment to abiotic and biotic surfaces. 
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MDR bacterial infections are becoming increasingly common in the hospital and 
community setting, emphasizing the need for new strategies that can effectively treat 
them. Over time, bacteria can develop resistance to existing drugs, making infections 
difficult, if not impossible, to treat. This scenario motivates prospective research towards 
the discovery of new antimicrobial active substances. Pioneering approaches, 
methodologies and technologies have promoted a new era in antimicrobial discovery. 
RNA sequencing procedures are evolving technologies that allow us to discover RNA 
expression profiles of any organism (262, 263). The low cost of sequencing combined 
with an increasing data output have accelerated RNA-seq based studies. Therefore, these 
new tools may be very useful to find new genes and resolve the structure of transcripts 
(264). 
RNA-seq has also become a standard method to analyse gene expression in bacterial 
infections since it can reveal infection-relevant RNA expression changes (265). 
Facilitating quantitative computational analysis, advances in RNA-seq technology have 
revolutionized the study of bacterial transcriptomes (266). Thus, transcriptional analyses 
have leaded to the identification of several A. baumannii genes involved in different 
biological processes related to pathogenesis and resistance to different compounds (267-
269). 
In the present study, Illumina RNA-seq was used to set up the transcriptional pattern of A. 
baumannii ATCC 17978 in biofilm-associated cells compared to planktonic cells. Several 
studies tried also to untangle the factors that regulate biofilm formation using different 
approaches such as proteomic analysis or random transposon mutagenesis (132, 270, 
271). Thereby, this is the first study that uses RNA sequencing for identifying new factors 
involved in biofilm production and maintenance. 
Our data showed notable differences in gene expression between biofilm and planktonic 
cells of A. baumannii ATCC 17978 strain, being 55 genes exclusively expressed in sessile 
cells. Some of them had been previously described as related to biofilm formation. One 
example is the type I pili encoded by csuA/BABCDE operon that seems to be required for 
attachment to plastic surfaces although is not involved in adherence of A. baumannii 
ATCC 19606
T
 to human cells (106, 107). Accordingly, our results showed that csuA and 
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csuB were exclusively expressed in biofilm cells and csuA/B, csuC, csuE, and csuD were 
highly expressed in biofilm cells compared to planktonic cells. However, the role of this 
operon in the ATCC 17978 strain remains unclear since previous in silico analyses 
revealed a deletion in the 5’-end of csuA/B, which could result in the abolishment of 
CsuA/B production, and a single bp insertion in csuB that truncated the open reading 
frame  (100, 101). 
Tomaras et al. reported that the expression of Csu usher-chaperone pili assembly system 
is controlled by BfmR/S, a two-component regulatory system that acts in response to 
environmental signals (108). As previously mentioned, both genes are involved in several 
biological processes related to virulence such as biofilm formation, adherence, and serum 
resistance (108, 109). Our data revealed an over-expression of the bfmR gene in biofilm-
associated cells compared to stationary cells even though it did not result to be a biofilm-
specific gene, which could cause the over-expression of genes belonging to the 
csuA/BABCDE operon. 
Our data revealed that some other transcriptional regulators were only expressed in 
biofilm, but most of them are still uncharacterized and their functions remain unknown. 
One of these regulators is the A1S_2042 gene, related to the TetR family, a widely 
distributed group of transcriptional repressors that are involved in multidrug resistance, 
catabolic pathways, and pathogenicity (272). The disruption of this gene exclusively 
expressed in sessile cells caused a decrease in the biofilm formation ability of the mutant 
strain, suggesting that the A1S_2042 gene could participate in biofilm regulation. 
Pili and fimbria are important elements for bacterial adhesion to biotic and abiotic 
surfaces as well as for motility (105). Genes A1S_1507, coding for a type I pili protein, 
and A1S_3168, coding for the TFP PilW, were selected for disruption in the present work 
since they were over-expressed in sessile cells compared to planktonic cells. Mutant 
strains showed a reduced capacity to form biofilm, confirming the role of these genes in 
the process. The A1S_1507 gene belongs to the A1S_1510-1507 chaperone-usher system, 
which was identified by Nait Chabane et al. as a pellicle-associated operon well 
conserved among different A. baumannii strains (111). Overall data indicated that pili and 
fimbria play a remarkable role in biofilm formation (105, 111). 
Discussion 
 
135 
 
Iron acquisition systems are important virulence factors, such as acinetobactin, which was 
proved to be required for A. baumannii ATCC 19606
T
 strain to persist within epithelial 
cells (153). Our data reflected the expression of some genes related to acinetobactin 
(A1S_2380 and A1S_2388) and ferredoxin (A1S_0945 and A1S_1779) only in biofilm 
cells and the over-expression of many genes involved in iron acquisition and transport 
compared to planktonic cells. These results correlate with those obtained by Marti et al. 
(271) that detected the over-expression of four siderophore iron uptake systems in cells in 
a late state of pellicle development. Modarresi et al. showed that low iron levels promoted 
siderophore activity, AHL production, and biofilm formation in several A. baumannii 
strains (273). Thus, iron starvation conditions in sessile cells could promote the 
expression of genes involved in the iron uptake process. However, the presence of this 
metal in the culture medium differentially affects biofilm formation depending on the 
strain (274), and the relationship between the iron-associated process and biofilm 
formation still remains unclear. 
The Bap protein of A. baumannii, homologue to the staphylococcal biofilm-associated 
protein, has been widely characterized as an important factor for the development of a 
mature biofilm structure as well as for adherence to biotic surfaces (116, 118). This 
protein has been described as highly polymorphic among strains (275). The bap gene is 
disrupted in the A. baumannii ATCC 17978 strain genome, resulting in the A1S_2724 
and A1S_2696 loci, separated by 30 kb due to chromosomal rearrangements (116, 275). 
In the present study those genes, homologues to bap, were found as over-expressed in 
biofilm-associated cells compared to exponential cells, suggesting that they may play a 
role in the biofilm formation ability of the ATCC 17978 strain. 
A membrane-associated protein OmpA has been extensively related with biofilm 
formation (121). However, our data did not match previous reports and revealed that 
ompA gene expression was down-regulated in biofilm-associated cells. Expression level 
of this protein in biofilm is a controversial issue since while Cabral et al. found it as up-
regulated in biofilm cells (270) and Marti et al. detected three mass isoforms of the 
OmpA protein under-expressed in pellicles (271). This phenomenon could be due to the 
utilization of different A. baumannii strains or to variations in the culture conditions, that 
could modify the structure and the amount of the biofilm formed (98, 276). OmpA was 
suggested to act in the initiation step of biofilm formation and iron starvation conditions 
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of the maturation step could decrease its expression (271). In the present study, other 
proteins as CarO (A1S_2538) and OprD-like (A1S_0201) were found as over-expressed 
in biofilm cells. Accordingly, these proteins were found to be up-regulated in previous 
proteomic studies (270, 271). The over-expression of these porins could complement the 
decrease of OmpA production, contributing to membrane permeability. 
Moreover, in our work, many genes involved in amino acid metabolism and transport 
were up-regulated in biofilm compared to planktonic cells, corroborating the results 
previously obtained by Cabral et al. (270). Accordingly, we also detected an over-
expression of genes encoding efflux system components, including a resistance-
nodulation-cell division type (RND efflux pump) in biofilm cells. Efflux pumps may 
contribute to the inherent resistance of biofilm-forming bacteria to antibiotics. 
Twelve genes, found as exclusively expressed in biofilm, encoded uncharacterized 
proteins. One of them, the A1S_0302 gene, was selected for disruption because of its high 
level of expression in biofilm cells. The corresponding mutant strain was significantly 
deficient in biofilm formation ability compared to the parental strain. Further studies are 
required in order to determine the role that this gene could play in biofilm formation and 
maintenance. 
The gene A1S_0114, which encodes an ACP, was over-expressed in biofilm cells and its 
expression level was the highest detected. Surrounding genes, from A1S_0112 to 
A1S_0118, were also found as significantly over-expressed in biofilm compared to 
planktonic cells, suggesting that these genes could act as an operon. A previous 
transcriptome analysis revealed that the expression of this cluster was activated by 
quorum sensing, pointing out the relationship between these genes and the homoserine 
lactone synthase encoded by the A1S_0109 gene (131). In the present work it was 
demonstrated that the loss of the A1S_0114 gene caused a noticeable decrease in biofilm 
formation ability. Complementation of the knockout mutant strain with a copy of the 
A1S_0114 gene resulted in a partial restoration of the biofilm production ability. 
Expression of A1S_0109, A1S_0112 and A1S_0113 genes was conditioned by the 
expression of the A1S_0114 gene, since its complete deletion caused a decrease in the 
expression level of these surrounding genes during the stationary phase of growth. Taking 
together these data indicate that all these genes could act as an operon where its 
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disruption could have polar effects. This could explain the partial restoration of the 
biofilm formation ability of the mutant during complementation procedures. 
Several studies of different A. baumannii strains suggested that the gene cluster 
A1S_0112-0119 could be a polycistronic operon (131, 277). Bioinformatic analysis 
showed that all genes from A1S_0112 to A1S_0119 were transcribed in the same 
direction and either overlapped or were separated by small intergenic regions, which 
suggests the polycistronic nature of this operon. This fact was confirmed by the RT-PCR 
procedures performed. Allen and Gulick proposed this cluster to act as a NRPS where the 
A1S_0112 gene may act as an adenylation domain and the A1S_0115 gene as a multi-
domain NRPS protein containing condensation, adenylation, peptidyl carrier protein 
(PCP), and thioesterase domains (277).  Furthermore, this operon was shown to play a 
role in different processes in A. baumannii, since disruption of genes A1S_0112 and 
A1S_0115 in a hyper-motile variant of A. baumannii ATCC 17978 abolished motility and 
ability to form pellicles of the mutant strains (132). Similarly, another study evidenced 
that insertions in genes A1S_0113 and A1S_0115 significantly reduced the migration 
capacity of A. nosocomialis M2 strain (131). Thereby, a deeper analysis of the mutant 
strain lacking the A1S_0114 gene was done in the present study in order to clarify how 
this specific gene affects biofilm, adherence and other virulence factors. 
SEM analysis of bacterial biofilms revealed that the A1S_0114 gene was needed for 
developing multicellular structures associated with mature biofilm. When the ability to 
adhere to human alveolar cells of the mutant strain lacking the A1S_0114 gene was 
tested, the outcome showed a 60% of reduction in the number of attached bacteria 
compared to the wild type strain. The knockout strain complemented with the pWH1266 
plasmid harbouring a copy of the A1S_0114 gene was able to restore the ATCC 17978 
phenotype, verifying the involvement of this gene in the interaction of A. baumannii with 
biotic surfaces. These results were confirmed by SEM analysis of infected A549 human 
alveolar polarized cells. Micrographs presented extensive damage to the surfactant layer 
as well as to the epithelial cells caused by the ATCC 17978 strain and an important 
number of wild type cells attached to alveolar cells. However, although the A1S_0114 
defective strain was also able to destruct the surfactant, it showed a poor adherent 
phenotype.  
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Since the A1S_0114 gene seemed to take part in the adherence to both biotic and abiotic 
surfaces, expression of different genes involved in these processes were checked. Results 
of RT-qPCR showed an increase of the expression of csuA/B in the knockout strain 
compared to the wild type strain. The CsuA/BABCDE pili assembly system plays a well-
known role in attachment to abiotic surfaces and its presence in pellicles of different 
strains (107, 111, 271). However, the csuA/BABCDE operon up-regulation in the mutant 
strain may be irrelevant as this system may not be functional in the ATCC 17978 strain 
due to an insertion in csuB and a deletion in csuA/B (100, 101). Nevertheless, the lack of 
the A1S_0114 gene prompted an over-expression of other pili-related genes such as 
A1S_0690, A1S_1510, and A1S_2091. The A1S_0690 gene is part of the A1S_0690-
0695 operon, a putative FilF-like type III pili over-produced in pellicle and detected in 
OMVs (271, 278).  
The A1S_1507-1510 operon encodes a type I pili, widely related to biofilm formation, 
which is in accordance with our previous results that showed that the A1S_1507 gene was 
highly expressed in biofilm cells and its disruption caused a decrease in biofilm 
formation. This operon, controlled by the global regulator H-NS and repressed under iron 
limitation conditions (156, 188), was detected in pellicles together with the A1S_2088-
2091 operon (111). Furthermore, the A1S_2091 gene was highly expressed in biofilm 
compared to planktonic cells and the deletion of the LH92_11085 gene of A. baumannii 
MAR002 strain, homologous to A1S_2091, reduced bacterial attachment to A549 cells 
and biofilm formation on plastic surfaces (110). Expression of the virulence factor OmpA 
was also significantly reduced in absence of the A1S_0114 gene, in agreement with 
previous works that identified this porin as an important factor for biofilm formation and 
for the interaction with eukaryotic cells (121, 279). Overall, these results suggest that the 
A1S_0114 gene may influence the expression of genes related to attachment and biofilm 
production. 
In the present study, the involvement of the A1S_0114 gene in A. baumannii virulence 
has been demonstrated by using different animal models. Thus, gene deletion caused an 
increase in the number of viable eggs of C. elegans in a fertility assay, a rise in the 
survival rate of G. mellonella and a lower bacterial burden in lungs of infected mice in a 
pneumonia model. Furthermore, growth of the knockout strain was not affected by the 
lack of the acyl carrier protein encoding gene, indicating that differences between the 
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wild type and the knockout strain could be due to the role of the A1S_0114 gene as a 
virulence factor. Nevertheless, a study that combined transposon mutagenesis and next-
generation sequencing (NGS) techniques identified genes from the A1S_0112-0119 
operon as not necessary for persistence of A. baumannii ATCC 17978 in mice lungs 
(124). With a similar approach, Subashchandrabose et al. identified genes involved in 
survival in a leukopenic mouse model of bloodstream infection. Although no transposon 
insertion in the A1S_0114 gene was detected, mutants in the rest of the genes of the 
operon exhibited reduced fitness during growth within the host but they did not reach the 
threshold to be considered critical for bacterial survival (280). Variations between our 
results and these studies may be due to differences in the methodology, such as distinct 
mice strains and infection routes used. Another study showed that genes belonging to this 
operon were also under-expressed during bacteraemia in a mice infection model 
compared to in vitro cells (267). Murray et al. reported that the majority of A. baumannii 
genes previously identified as necessary for virulence were either under-expressed or 
their expression did not change in vivo (267). In fact, they noted a general down-
regulation of several genes involved in biofilm and pili biosynthesis, such as 
csuA/BABCDE and A1S_2088-2091 operons, the transcriptional regulator bfmR, and the 
homoserine lactone synthase abaI (267). These authors suggested that the reduced 
expression of those biofilm-related genes may be due to the planktonic state of the 
bacterial cells causing blood infection, explaining that these genes  could be required for 
virulence in later stages of  septicaemia or tissues infections (267). 
Due to the putative functions of the proteins encoded by the A1S_0112-0119 operon, 
Allen and Gulick indicated that it could be acting as a NRPS (277). The A1S_0112 gene 
encodes an acyl-CoA synthase/AMP-acid ligase that could activate and transfer fatty 
acids to ACPs via acyl AMP intermediates. The A1S_0113 gene, encoding an acyl-CoA 
dehydrogenase, is predicted to modify the intermediate product carried by an ACP or PCP 
domain. The acyl carrier protein encoded by the A1S_0114 gene is likely to contribute a 
tethered intermediate to the NRPS system involved in the biosynthesis of a secondary 
metabolite (277). The A1S_0115 gene is predicted to encode a four-domain 
(condensation, adenylation, PCP, and thioesterase) NRPS protein with a thioesterase 
domain most likely responsible for the release of acyl/peptide chains from their covalent 
attachment to the ACP/PCP domains (281). The A1S_0116 gene encodes a protein that 
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belongs to the superfamily of RND transporters and could be potentially involved in the 
secretion of the secondary metabolite synthetize by this operon. The A1S_0117 and 
A1S_0118 genes are annotated as hypothetical proteins (162), but in silico analysis 
showed that they could be related to porins and epimerase/dehydratase enzymes, 
respectively. Finally, the A1S_0119 gene encodes a phosphopantetheine transferase that 
is expected to perform the activation of the ACP. All these predictions are in accordance 
with the observation that the expression of the A1S_0114 gene is required for the 
production of the Ac-505 secondary metabolite. 
This compound, present in culture supernatants of the ATCC 17978 strain but absent in 
those from the knockout strain, seems to be a three-amino acid lipopeptide. However, 
bonds between the amino acids as well as to the hydrocarbon moiety are non-standard. 
Whereas the second and third amino acids are Cys and Gly residues linked via standard 
peptide linkage, they are connected to the Gly-containing moiety through the sulfur group 
of the Cys side chain forming a thioether bridge. The Cys-Gly moiety could be potentially 
derived from glutathione (L-γ-glutamyl-L-cysteinyl-glycine), a tripeptide found in high 
concentrations intercellularly in A. baumannii and that maintains a proper cellular redox 
state (282). Ac-505 may be the result of the glutathione-mediated de-activation of a 
secondary metabolite but the structure of this potential precursor remains unknown. 
Modification of this precursor by glutathione could explain that Ac-505 could not be able 
to restore the wild type phenotype when added to the mutant strain (data not shown). 
To summarize, we can conclude that the A1S_0114 gene affects A. baumannii biofilm 
formation, adherence to eukaryotic cells as well as virulence responses and that it is 
involved in the biosynthesis of a novel metabolite. Further analysis are required in order 
to determine the mechanisms by which this gene acts and if Ac-505 is responsible for 
these responses. 
Many genes have been described to date as involved in biofilm biogenesis and 
maintenance. However, little is known about the sRNAs that may be involved in this 
process regulation. Therefore, in the present work a transcriptional analysis of the sRNAs 
produced by planktonic cells and biofilm-associated cells was performed to identify those 
small RNAs of A. baumannii ATCC 17978 involved in biofilm formation. 
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The first sRNAs were discovered in E. coli in biochemical or functional screens, aided by 
their relative abundance (283). In the latest decades numerous studies used comparative 
genomics, secondary structure prediction, and computational analysis searching for 
promoters and terminators in intergenic regions to identify potential sRNA candidates 
(215). Shotgun cloning or microarray analysis of cDNA added new molecules to the pool 
of putative sRNAs (284, 285). The development of NGS technologies for cDNA 
sequencing has revolutionized the identification of novel noncoding transcripts (286). 
Recently, novel deep sequencing techniques as global mapping of transposon insertion 
sites, measuring translatomes using ribosome profiling, and analysis of RNA-protein 
complexes have facilitated the identification and functional characterization of multiple 
sRNAs (287-289). 
Consequently, following NGS procedures in biofilm and in exponential and stationary 
growth phase samples we were able to identify 255 putative sRNAs that were expressed 
in at least one of the conditions, being 185 of them differentially expressed. This number 
was significantly bigger than the data obtained by Weiss et al. where 78 sRNA were 
detected in A. baumannii AB5075 (259). However, conservation of sRNAs among 
different strains is infrequent not only in A. baumannii, but also in P. aeruginosa where 
multiple sRNAs exhibit strain-specific expression patterns (290, 291). Also, depending on 
the approach used for the library preparation or the timing for RNA extraction, different 
set of sRNAs could be detected (292).  
Accordingly, Sharma et al. predicted 31 sRNAs in silico from A. baumannii ATCC 17978 
(258) and only 18 of them were also detected in our study. A group of 10 of the 31 
sRNAs predicted by Sharma et al. were analysed in A. baumannii MTCC1425 and 3 of 
them showed positive signal on Northern blot. In particular, the sRNAs AbsR25 and 
AbsR28 described by Sharma et al. corresponded to the putative sRNAs 10452 and 22397 
described in the present study, respectively. Moreover, while they found variable 
expression level of the sRNA AbsR25 during different phases of planktonic growth (258), 
we did not find the sRNA 10452, its homologue, as differentially expressed under our 
experimental conditions. Moreover, the length of both sequences detected in the ATCC 
17978 and the MTCC1425 strains did not match, probably due to genomic variations 
between these strains or to the distinct bioinformatics approaches used. 
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We found 28 of the 185 differentially expressed sRNAs as over-expressed and 32 down-
regulated in biofilm compared to planktonic cells. Nine sRNAs were exclusively 
expressed in biofilm and 21 were only detected in planktonic cells. Gene expression of 
the sRNAs most over-expressed in biofilm was confirmed by RT-qPCR analysis, those 
being the 13573 sRNA and six sRNAs not present either in exponential or in stationary 
growth phase. The outcome obtained validated the results previously obtained by 
pyrosequencing, indicating that the profile of sRNAs produced is significantly different 
depending on the lifestyle. 
Small RNA 13573 was selected for further characterization due to its high over-
expression level in biofilm cells. The effect of the 13573 sRNA in different biological 
processes was investigated. Biofilm formation analysis showed that, the 13573 sRNA has 
an effect on the biofilm formation ability of the strain, since its over-expression prompted 
a 2-fold increase of biofilm formation. SEM images exposed that 13573 was able to 
develop a mature biofilm structures, unlike the wild type and mutant strains, which 
presented unorganized cells. Moreover, cells from the knockout strain showed more 
dispersion than the parental strain. Several sRNAs have been described as regulators 
implicated in biofilm formation in Pseudomonas, Vibrio, and in E. coli (93, 236). In 
previous works it was shown that over-expression of sRNAs RseX, CsrC or SgrS sRNAs 
from E. coli increased biofilm formation but its deletion did not cause the opposite effect 
(227). In fact, in the same study they detected that, after over-expressing and deleting 99 
sRNAs in E. coli, only a few deletions  had effects on biofilm formation (227). This 
correlates with the results that we have observed for the 13573 sRNA of A. baumannii 
ATCC 17978. The strain over-expressing the 13573 sRNA produced higher amount of 
biofilm than the wild type strain but its deletion did not affect biofilm formation. This 
effect could be due to several issues, such as redundancy of sRNAs acting on the same 
process, other sRNAs regulating the activity of transcriptional regulators involved in 
biofilm formation, or expression levels of sRNAs that do not reach the threshold to affect 
this biological process under particular experimental conditions. Therefore, we found that 
the over-expression of the 13573 sRNA has a remarkable effect on biofilm production but 
the impact of its deletion could be neutralized by other sRNAs. A more exhaustive study 
is required in order to untangle the mechanisms used by the 13573 sRNA to regulate this 
process. 
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Adhesion assays allowed us to elucidate the role of the 13573 sRNA on host-pathogen 
interaction. The ability to attach to A549 human alveolar cells decreased in the knockout 
strain lacking the 13573 sRNA compared to the ATCC 17978 strain. However, when the 
13573 sRNA was over-expressed, a significant higher number of bacteria were attached 
to the biotic surface. No colonies were detected when invasiveness ability of the strains 
was tested. Therefore all the CFUs counted after 24 h of incubation were due to the 
attachment capacity of the different strains. SEM analysis of bacterial strains infecting 
polarized A549 cells supported these previous results, revealing that only the strain over-
expressing 13579 sRNA was able to form a tridimensional biofilm over the cell layer. 
There is not a clear relationship between the ability to form biofilms and the capacity to 
adhere to biotic surfaces as described by Eijkelkamp et al. in different strains of A. 
baumannii (100). Data revealed that not all the genes involved in biofilm formation play 
also a role in attachment to biotic surfaces. An example is the csuE gene, which is not 
implicated in the adherence to human cells even though it is in biofilm formation on 
abiotic surfaces (106, 107). Regarding sRNAs, little is known about the role they play in 
adhesion to eukaryotic cells. One example is FasX from Streptococcus, which inhibits the 
expression of a cell surface pilus, reducing the capacity of the bacteria to attach to host 
cells (293). Hence, we can affirm that 13573 is the first sRNA described in A. baumannii 
as involved in biological processes such as biofilm formation and attachment to biotic 
surfaces. 
To sum up, in the present work were identified different patterns of gene expression of 
both mRNAs and sRNAs in biofilm-associated cells compared to planktonic cells from 
exponential or stationary growth stages. The analysis of these patterns allowed us to 
identify genes and sRNAs that may play a role in the regulation of the sessile lifestyle 
adoption. Therefore, we demonstrated that the A1S_0114 gene, which encodes an ACP 
being part of the A1S_0112-0119 operon, is involved not only in biofilm production and 
maintenance, but also in adherence to human alveolar cells, virulence and the 
biosynthesis of the metabolite Ac-505. On the other hand, this study highlighted the 
potential role of the 13573 sRNA in biofilm formation regulation and adherence to 
eukaryotic cells. This is the first work where biofilm formation and attachment have been 
reported as positively regulated by sRNAs in A. baumannii. 
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1. Biofilm associated cells of A. baumannii ATCC 17978 present a mRNA pattern 
that significantly differs from planktonic cells, showing a collection of 
differentially expressed genes where some of them are exclusively expressed in 
sessile cells. 
 
2. A hypothetical protein, a fimbrial protein encoded, a pilus assembly protein, and a 
transcriptional regulator, encoded by the A1S_0302, the A1S_1507, the 
A1S_3168, and the A1S_2042 genes, respectively, are involved in biofilm 
formation of A. baumannii ATCC 17978. 
 
3. The A1S_0114 gene of A. baumannii ATCC 17978, coding for an acyl-carrier 
protein, plays a role in biofilm formation, in attachment to biotic and abiotic 
surfaces, in virulence, and in the biosynthesis of the metabolite acinetin 505, this 
being a novel factor involved in the pathogenesis of this strain. 
 
4. The A. baumannii ATCC 17978 strain expresses a remarkable number of sRNAs, 
being their expression level dependent on the stage of growth.  
 
5. A total amount of 185 sRNAs are differentially expressed in biofilm associated 
cells of the A. baumannii ATCC 17978 strain compared to both exponential and 
stationary phase cells suggesting that they may play a role in biofilm formation 
regulation. 
 
6. The 13573 sRNA regulates biofilm formation and attachment to eukaryotic cells, 
being these biological processes related to the pathogenesis of A. baumannii 
ATCC 17978. 
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Figure S1 
Gene level counts. Left: boxplot (median, first and third quartiles and standard deviation) 
of the number of reads per gene. Right: density functions of the number of reads per gene. 
 
 
Figure S2 
MD plots and correlation between samples. Upper right: MD plots showing 
(countsA+countsB)/2 against (countsA-countsB), with A and B being the samples shown 
on the diagonal. 
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Figure S3 
Sequence distribution of genes up-regulated in biofilm-associated cells. The data were 
filtered based on p < 0.001 and with respect to biological processes. A) Exponentially 
growing cells, filtered by the number of sequences (cutoff 6). B) Stationary phase cells, 
filtered by the number of sequences (cutoff 1). 
 
 
Table S1 
Gene expression data from the complete transcriptome analysis of Acinetobacter 
baumannii ATCC 17978, showing gene expression levels in exponentially growing vs. 
stationary phase cells. Id: name or code of the region of interest; baseMean: mean of the 
two next columns; baseMeanA: normalized number of counts for sample A; baseMeanB: 
Supplementary material Chapter I 
 
185 
 
normalized number of counts for sample B; Fold-change: baseMeanB/baseMeanA, 
log2Fold-change: log2 baseMeanB/baseMeanA, pval: p value, padj: p value adjusted for 
multiple testing, resVarA: variance of A, resVarB: variance of B.A: stationary phase 
cells. B: exponential phase cells. NA, non-applicable because of zero expression. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s004.xlsx 
 
Table S2 
Gene expression data from the complete transcriptome analysis of Acinetobacter 
baumannii ATCC 17978, showing gene expression levels in biofilm-associated cells vs. 
exponentially growing cells. Id: name or code of the region of interest; baseMean: mean 
of the two next columns; baseMeanA: normalized number of counts for sample A; 
baseMeanB: normalized number of counts for sample B; Fold-change: 
baseMeanB/baseMeanA; log2Fold-change: log2 baseMeanB/baseMeanA; pval: p value; 
padj: p value adjusted for multiple testing; resVarA: variance of A; resVarB: variance of 
B.A: exponential phase cells. B: biofilm-associated cells. NA, non-applicable because of 
zero expression. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s005.xlsx 
 
Table S3 
Gene expression data from the complete transcriptome analysis of Acinetobacter 
baumannii ATCC 17978, showing gene expression levels of biofilm-associated vs. 
stationary phase cells. Id: name or code of the region of interest; baseMean: mean of the 
two next columns; baseMeanA: normalized number of counts for sample A; baseMeanB: 
normalized number of counts for sample B; Fold-change: baseMeanB/baseMeanA; 
log2Fold-change: log2 baseMeanB/baseMeanA; pval: p value; padj: p value adjusted for 
multiple testing; resVarA: variance of A; resVarB: variance of B.A: stationary phase 
cells. B: biofilm-associated cells. NA: non-applicable because of zero expression. 
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https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s006.xlsx 
 
Table S4 
The expression levels of genes down-regulated in biofilm-associated vs. stationary phase 
cells. The data were filtered based on p < 0.001. Id: name or code of the region of 
interest; baseMean: mean of the two next columns; baseMeanA: normalized number of 
counts for sample A; baseMeanB: normalized number of counts for sample B; Fold-
change: baseMeanB/baseMeanA; log2Fold-change: log2 baseMeanB/baseMeanA; pval: p 
value; padj: p value adjusted for multiple testing; resVarA: variance of A; resVarB: 
variance of B.A: stationary phase cells. B: biofilm-associated cells. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s007.xlsx 
 
Table S5 
The expression levels of genes up-regulated in biofilm-associated vs. stationary phase 
cells. The data were filtered based on p < 0.001. Id: name or code of the region of 
interest; baseMean: mean of the two next columns; baseMeanA: normalized number of 
counts for sample A; baseMeanB: normalized number of counts for sample B; Fold-
change: baseMeanB/baseMeanA; log2Fold-change: log2 baseMeanB/baseMeanA; pval: p 
value; padj: p value adjusted for multiple testing; resVarA: variance of A; resVarB: 
variance of B.A: stationary phase cells. B: biofilm-associated cells. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s008.xlsx 
 
Table S6 
The expression levels of genes down-regulated in exponentially growing vs. stationary 
phase cells. The data were filtered based on p < 0.001. Id: name or code of the region of 
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interest; baseMean: mean of the two next columns; baseMeanA: normalized number of 
counts for sample A; baseMeanB: normalized number of counts for sample B; Fold-
change: baseMeanB/baseMeanA; log2Fold-change: log2 baseMeanB/baseMeanA; pval: p 
value; padj: p value adjusted for multiple testing; resVarA: variance of A; resVarB: 
variance of B.A: stationary phase cells. B: exponential phase cells. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s009.xlsx 
 
Table S7 
The expression levels of genes up-regulated in exponentially growing vs. stationary phase 
cells, filtered based on p < 0.001. Id: name or code of the region of interest; baseMean: 
mean of the two next columns; baseMeanA: normalized number of counts for sample A; 
baseMeanB: normalized number of counts for sample B; Fold-change: 
baseMeanB/baseMeanA; log2Fold-change: log2 baseMeanB/baseMeanA; pval: p value; 
padj: p value adjusted for multiple testing; resVarA: variance of A; resVarB: variance of 
B.A: stationary phase cells. B: exponential phase cells. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s010.xlsx 
 
Table S8 
The expression levels of genes down-regulated in biofilm-associated vs. exponentially 
growing cells. The data were filtered based on p < 0.001. Id: name or code of the region 
of interest; baseMean: mean of the two next columns; baseMeanA: normalized number of 
counts for sample A; baseMeanB: normalized number of counts for sample B; Fold-
change: baseMeanB/baseMeanA; log2Fold-change: log2 baseMeanB/baseMeanA; pval: p 
value; padj: p value adjusted for multiple testing; resVarA: variance of A; resVarB: 
variance of B.A: exponential phase cells. B: biofilm-associated cells. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s011.xlsx 
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Table S9 
The expression levels of genes up-regulated in biofilm-associated vs. exponentially 
growing cells. The data were filtered based on p < 0.001. Id: name or code of the region 
of interest; baseMean: mean of the two next columns; baseMeanA: normalized number of 
counts for sample A; baseMeanB: normalized number of counts for sample B; Fold-
change: baseMeanB/baseMeanA; log2Fold-change: log2 baseMeanB/baseMeanA; pval: p 
value, padj: p value adjusted for multiple testing; resVarA: variance of A; resVarB: 
variance of B.A: exponential phase cells. B: biofilm-associated cells. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758355/bin/pone.0072968.s012.xlsx 
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Figure S1 
Confirmation of the polycistronic nature of the A. baumannii ATCC 17978 A1S_0112-
A1S_0119 operon. Total DNA (lanes 2–7), cDNA (lanes 8–13) and total RNA (lanes 14–
19) samples were used as templates in PCR reactions using primers annealing to the 
A1S_0112-A1S 0113 (lanes 2, 8, and 14), A1S_0113-A1S_0115 (lanes 3, 9, and 15), 
A1S_0115-A1S_0116 (lanes 4, 10, and 16), A1S_0116-A1S_0117 (lanes 5, 11, and 17), 
A1S_0117-A1S_0118 (lanes 6, 12, and 18), and A1S_0118- A1S_0119 (lanes 7, 13, and 
19) intergenic regions. Lanes 1 and 20 show the molecular weight standard Gene Ruler 1-
Kb plus (Thermofisher Scientific). Molecular weight of each amplicon is indicated at the 
bottom of the figure. 
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Figure S2 
Growth of the 17978 parental and the Δ0114 isogenic deletion derivative strains. The 
OD600 values of each strain grown in LB or SB at 37°C for 24 h with shaking were 
determined hourly. Error bars represent the standard error (SE) of the mean. 
 
 
 
Figure S3 
Ac-505 MS/MS spectra. (A) MS data collected on the FT-ICR with ECD fragmentation 
in positive ion mode. (B) MS/MS collected on a MaXis QTOF in positive ion mode (LC-
MS) and (C) negative ion mode (direct injection). 
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Figure S4 
MS/MS—based fragmentation predictions (A,B) are two of the 40 total MSn spectra from 
MS(3) to MS(6) recorded on the OSU Bruker amaZon in positive ion mode using direct 
injection of a HPLC purified Ac-505. MS(2) for 488.3 and MS(4) for 235.2 m/z fragment 
ions are shown in (A,B), respectively. Neutral losses are shown in black. Panel (C) is a 
schematic diagram of MS/MS fragmentation of Ac-505 in positive ion mode and (D) is 
for negative ion mode. 
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Figure S5 
Predicted product ions of Ac-505 based on accurate mass and typical bond cleavage 
patterns under electrospray conditions in positive ion mode. 
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Figure S6 
Predicted product ions of Ac-505 based on accurate mass and typical bond cleavage 
patterns under electrospray conditions in negative ion mode. 
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Table S1 
Oligonucleotides used in the present study. 
 
Primer name Sequence (5’-3’) Purpose 
0114UpFPstI CCCCTGCAGGGGTTGGTACGTGAGC
AACTC 
Construction of 
Δ0114 
0114UpREcoRI GGGGAATTCCCCGCGCTCCAGTAAG
CTTT 
Construction of 
knockout strain 
Δ0114 
0114DownFEcoRI CCCGAATTCGGGGAGCCAACACTAT
TATGGGA 
Construction of 
Δ0114 
0114DownRBamHI GGGGGATCCCCCTCTCATAATCTTT
CGCCAAG 
Construction of 
Δ0114 
0114extF CAAGGAGTTTGAAACGAT Confirmation of 
Δ0114 
0114extR CTCGCAGCAATAGACCAA Confirmation of 
Δ0114 
0114EcoRVF CCCGATATCGGGACCGGTTAAAAAG
GAGATTAC 
Complementation 
of 17978 Δ114  
0114BamHIR GGGGGATCCCCCCTGGTTCTAGTCG
TGCAA 
Complementation 
of 17978 Δ114 
pWH1266Fw TAGGCTTGGTTATGCCGGTA Confirmation the 
complementation 
of the 
17978Δ0114 
pWH1266Rv AAGGAGCTGACTGGGTTGAA Confirmation the 
complementation 
of the 
17978Δ0114 
KanaRPstIFw 
 
CCCCTGCAGGGGCCGGAATTGCCAG
CTGGGGCG 
Cloning the 
kanamycin 
resistance gene 
into pWH1266 
plasmid 
KanaRPstIRv GGGCTGCAGCCCTCAGAAGAACTCG
TCAAGAAG 
Cloning the 
kanamycin 
resistance gene 
into pWH1266 
plasmid 
0112F TTACTGCACCAAGGCCGAAT Check expression 
of the operon 
0113R AATTTCCATGCGACCTCCGA Check expression 
of the operon 
0113F GCTCGTATTGCTGTGTTGGG Check expression 
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of the operon 
0115R CTTACGCGCAGTAGCGGATA Check expression 
of the operon 
0115F CCTCTCGATGCAGACCCATC Check expression 
of the operon 
0116R CGTACCTTCCGGATGTGGTT Check expression 
of the operon 
0116F CCGATATCCGTCCTTACGGC Check expression 
of the operon 
0117R GGGTTTACAGTGTGGTCCGT Check expression 
of the operon 
0117F GAGCTATGCTGCGTTATGCG Check expression 
of the operon 
0118R TTGTCTGGGCGTCCGATAAT Check expression 
of the operon 
0118F CTGGCGCAGGTCATAATCCA Check expression 
of the operon 
0119R AATAAGGTCCGCGGAGTGAC Check expression 
of the operon 
csuA/B F GCAGCTGTTACTGGTCAG qRT-PCR 
csuA/B R GTCTGTGCGTTCACCACC qRT-PCR 
A1S_2091 F GTCCACCATCAAATGACAAAGTCC qRT-PCR 
A1S_2091 R CTGTGTCCTGAATACCTCAGC qRT-PCR 
A1S_1510 F GATGTTGCTGGTCGTACACC qRT-PCR 
A1S_1510 R GACATTGGTAGCTGCACCAG qRT-PCR 
A1S_0690 F AAACAACCGCAACTCGTGG qRT-PCR 
A1S_0690 R CAGCGGCGTCTTTAATACC qRT-PCR 
ompA F CGACGCTTTATCTCTTCG qRT-PCR 
ompA R GGAGCAGCAGGCTTGAAG qRT-PCR 
recA F TACAGAAAGCTGGTGCATGG qRT-PCR 
recA R TGCACCATTTGTGCCTGTAG qRT-PCR 
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Table S2 
HRMS data of Ac-505. Measured m/z-values are reported for MS fragment ions measured 
on ESI MaXis QTOF (LC-MS2) and 15T FT-ICR ECD (direct infusion) instruments in 
positive ion mode, respectively. The molecular formulas of the product ions are based on 
accurate mass and isotopic pattern matching of the ions as well as typical bond cleavage 
patterns for electrospray ionization. 
 
 
 
Table S3 
HRMS data of Ac-505 and MS2 fragments measured on a ESI MaXis QTOF (direct 
infusion) in negative ion mode. 
 
Formula Calc. (m/z) Measured (m/z) D ppm err. Measured (m/z) D ppm err. 
    MaXis QTOF   15T FT-ICR 
 C46H87N6O14S2
+
 1011.57162 1011.5718 0.2   
 C23H43N3O7SNa
+
    528.27139 528.2718 0.8 528.27144 0.1 
C23H44N3O7S
+
    506.28945 506.2921 5.2 506.28945 0.0 
C23H42N3O6S
+
    488.27888 488.2813 5.0 488.27876 -0.2 
C23H39N2O6S
+
 471.25233   
 
471.25221 -0.3 
C21H37N2O4S
+
 413.24686 413.2487 4.5 413.24676 -0.2 
C20H37N2O3S
+
 385.25194 385.2541 5.6 385.25187 -0.2 
C20H34NO3S
+
 368.22539   
 
368.22534 -0.1 
C18H34NO3S
+
 344.22539   
 
344.22536 -0.1 
C18H32NO3
+
 310.23767 310.2390 4.3 310.23762 -0.2 
C9H13N2O6S
+
 277.04888 277.0502 4.8 277.04884 -0.1 
C16H27O
+
 235.20564 235.2064 3.2 235.20566 0.1 
C5H9N2O3S
+
 177.03284 177.0333 2.6 177.03286 0.1 
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Text S1 
Additional details about 454 read data processing. 
Processing of sRNA 454 sequencing reads 
sRNA fractions, obtained from liquid A. baumannii ATCC 17978 cultures in the 
exponential and stationary phases of growth, plus biofilms were pyrosequenced at the 
Roche 454 Sequencing Center (Connecticut, USA) using GS FLX Titanium chemistry. 
The total number of reads was 689,097, 502,152 and 627,209 for the exponential, 
stationary and biofilm samples, respectively. FASTA formatted sequences and quality 
values extracted from SFF files were used as input for cross-match (Phred-Phrap-Consed 
package) to mask the sequence of the adapters used with the SREK kit (Table S1). 
Masked segments were then removed with Trimseq (Emboss package). No procedure to 
eliminate identical reads was performed, given that the pyrosequencing libraries consisted 
of short cDNA sequences representing, in principle, full-length sRNAs and the presence 
of identical reads was expected. 
Pre-processed reads were aligned with cross-match against the A. baumannii ATCC 
17978 chromosome and plasmid nucleotide sequences (Genbank: NC_009085, 
NC_009083 and NC_009084). Alignments were filtered with an ad-hoc Perl script 
(crossMatchParser) to recover, for each read, those alignments with the highest score and 
fulfilling the minimal requirements of 90% identity and 15-base pair length. Between 
32 % and 43 % of pre-processed reads could be aligned for each sample (Table S2). The 
total number of filtered alignments was around twice the number of aligned reads, 
indicating that a significant number of reads could align to more than one location with 
the same score. 
Quantification of the expression level for known sRNA genes 
To estimate the expression level for known sRNA genes described for A. baumannii 
ATCC 17978, which included 74 genes coding for 5S rRNAs and tRNA, filtered 
alignments were processed with the ad-hoc script mapAlignHits, which in “expression 
mode” calculated the average coverage for sets of target sequence segments defined by 
gene coordinates. Relative abundance (RA) values were also calculated for known protein 
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coding genes and for 16S and 23S rRNA genes (Table S3). Reads aligning to multiple 
locations with identical score contributed to the coverage of each region with an amount 
that was inversely proportional to the number of locations. The resulting average 
coverage values were normalized to obtain relative abundance (RA) values, by dividing 
them by the total number of mapped reads for each sample, and multiplying them by the 
number of mapped reads for the exponential phase sample, which was defined as the 
reference condition. tRNA and 5S rRNA genes had RA values of 1,092 to 1,338, in 
average, for the three samples, which were more than 1,000-fold and about 20-fold higher 
than RA values calculated for protein coding genes and 16S and 23S rRNA genes, 
respectively (Table S4 and Figure S1), suggesting that sRNA fractions isolated as 
described in Methods were significantly depleted of mRNA and rRNA. A1S_2909, 
coding for Leu tRNA, was the known sRNA gene expressed at the highest level, with a 
RA value of 18,693 in the stationary phase sample. In contrast, A1S_2764, coding for 
Arg tRNA, was the known sRNA gene expressed at the lowest level, with a RA value of 
7.6 in the exponential phase sample.  
Identification of new sRNA gene candidates  
To identify new sRNA gene candidates, filtered alignments were combined into a single 
file and processed with script mapAlignHits, which, in “detection mode” identified 
continuous read-covered regions, with a minimal average coverage of 1, in target 
sequences (chromosome and plasmids). A total of 26,956 read-covered regions 
(exprRegs) were detected. To identify read-covered regions overlapping with known 
genes, the ad-hoc script FindOlappingFeatures was used to compare their coordinates 
with the coordinates of 3,451 known protein, tRNA and rRNA coding genes. The 
minimal overlap required to consider two features as overlapping was set to 0.001 % of 
the length of any of the features. A total of 21,392 exprRegs were found to overlap with 
already described genes. The remaining 5,564 exprRegs (Dataset S1) were considered as 
new potential sRNA genes. However, since the coordinate set used to define known 
protein coding genes referred exclusively to coding regions, some of the 5,564 exprRegs 
could correspond to 5' or 3' UTRs of genes that had not been covered by a single, 
continuous alignment, spanning the whole length of the transcribed region. New sRNA 
gene candidates were identified both in chromosome and plasmids (5,505 and 59 genes, 
respectively). Their average length was 63.39 base pairs (Figure S2). 
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Figure S1 
Distribution of normalized expression scores for known sRNA genes. Blue: biofilm 
samples. Orange: exponential phase samples. Yellow: stationary phase samples. 
 
 
Figure S2 
Distribution of normalized expression scores for the 5564 expressed regions not 
overlapping with known genes. Blue: biofilm samples. Orange: exponential phase 
samples. Yellow: stationary phase samples. 
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Figure S3 
Distribution of normalized expression scores for the 255 expressed regions not 
overlapping with known genes and having a normalized expression score equal or higher 
than 7.6 in some of the growing conditions. Blue: biofilm samples. Orange: exponential 
phase samples. Yellow: stationary phase samples. 
 
 
Figure S4 
qRT-PCR assays. Expression levels of 8 sRNA regions in planktonic and sessile cells 
determined by qRT-PCR using Taqman probes. Y axis represents the relative expression 
of the genes taking the housekeeping gene gyrB as value 1. 
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Figure S5 
Biofilm formation at different times. Staining at 12, 24 and 48 h of biofilm formation of 
A. baumannii ATCC 17978 (17978), A. baumannii ATCC 17978 Δ13573 (Δ13573), A. 
baumannii ATCC Δ13573 harbouring pETRA with sRNA 13575 (Δ13573 
complemented), A. baumannii ATCC 17978 harbouring pETRA with sRNA 13575 
(13573), and A. baumannii ATCC 17978 harbouring pETRA (17978 with empty 
pETRA). 
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Figure S6 
Growth curves. Growth curves of wild type A. baumannii (17978), A. baumannii ATCC 
17978 lacking the sRNA 13573 (Δ13573), A. baumannii Δ13573 over-expressing sRNA 
13575 (Δ13573 complemented), A. baumannii ATCC 17978 harbouring pETRA over-
expressing sRNA 13575 (13573) and A. baumannii ATCC 17978 harbouring the empty 
pETRA vector (17978 with empty pETRA). 
 
 
Table S1 
Oligonucleotides and probes used in the present study. 
Oligonucleotide 
name 
Oligonucleotide sequence Use of the oligonucleotides 
 
13573 F ccctctagagggattattatgactgcttaaatc Over-expression of sRNA 
13573 in pETRA 
13573 R gggccatggcccaataggttagtaaggtaataa Over-expression of sRNA 
13573 in pETRA 
KM F cccctgcaggggccggaattgccagctggggcg Cloning kanamycin resistance 
cassette in pETRA 
KM R gggctgcagccctcagaagaactcgtcaagaag Cloning kanamycin resistance 
cassette in pETRA 
SREK 1 ctgccccgggttcctcattctctgcggtcctgctgta Construction of cDNA 
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cggccaaggcg libraries 
SREK (Ambion) 
SREK 2 ccactacgcctccgctttcctctctatgggcagtcg
gtgat 
Construction of cDNA 
libraries 
SREK (Ambion) 
13573BUpFNot
I 
cccgcggccgcgggttggtcaaaggtgtgaaaat
gt 
Construction of the knockout 
mutant of sRNA 13573 
13573 UpR3 
BamHI 
gggggatcccccactaaagtatctatttgggtgtac
g 
Construction of the knockout 
mutant of sRNA 13573 
13573 DownF3 
BamHI 
cccggatccgggaggatcggttattgaatcag Construction of the knockout 
mutant of sRNA 13573 
13573DownRS
phI 
ggggcatgcccccaagtcacaagcaccttcttt Construction of the knockout 
mutant of sRNA 13573 
13573extF2 tataaggtgtaagcacgctg Checking of the knock-out 
mutant of sRNA 13573 
13573extR2 tcacgagacaagagatgaac Checking of the knockout 
mutant of sRNA 13573 
 
 
Table S2 
Number of initial reads, mapped reads and alignment hits for each sample. 
Sample Number of Reads Number of Mapped Reads  Number of Hits 
Exp 689,097 298,048 (43%) 691,710 
Sta 502,152 176,003 (35%) 429,806 
Bio 627,209 204,637 (32%) 505,760 
Biofilm: Bio. Exponential phase of growth: Exp. Stationary phase of growth: Sta. 
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Table S3  
A. baumannii known sRNA and non-sRNA genes used as reference. 
Gene set Subset Number of genes 
rRNA 5S Known sRNA  5 
tRNA Known sRNA 69 
rRNA 16S and 23 S Known, non sRNA 10 
Protein coding Known, non sRNA 3,367 
 
 
Table S4  
Average, standard deviation, maximal and minimal values for the normalized expression 
scores calculated for protein coding genes, 16S and 23S rRNA genes and known sRNA 
genes, in each of the growing conditions.  
 Protein Coding 16S, 23S tRNA, 5S 
 BioN ExpN StaN BioN ExpN StaN BioN ExpN StaN 
Ave 0.62 1.05 1.15 57.27 35.41 61.07 1,260.37 1,092.71 1,338.55 
Std 1.03 1.27 1.32 1.72 3.09 16.6 2,719.95 1,797.35 2,689.99 
Max 20.34 26.49 27.48 59.15 38.44 77.3 18,375.78 9,944.99 18,693.1 
Min 0 0 0 55.65 32.08 45.3 15.9 7.6 14.93 
Biofilm: BioN. Exponential phase of growth: ExpN. Stationary phase of growth: StaN. 
Average: Ave. Standard deviation: Std. Maximal values: Max. Minimal values: Min. 
 
 
Table S5  
Average, standard deviation, maximal and minimal values for the normalized expression 
scores calculated for 5564 expressed regions not overlapping with known genes. 
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 Bio Exp Sta 
Ave 1.83 2.01 2.06 
Std 20.62 12.96 27.64 
Max 826.28 484.14 1,728.21 
Min 0 0 0 
Biofilm samples: Bio. Exponential phase of growth samples: Exp. Stationary phase of 
growth samples: Sta. Average: Ave. Standard deviation: Std.  
 
Table S6 
Sets of expression regions not overlapping with known genes and having a normalized 
expression score equal or higher than 7.6 in some of the three growing conditions. 
 Bio Exp Sta 
Number of expression 
regions 
108 140 121 
Average normalized 
score 
57.88 35.64 54.53 
Standard deviation 137.16 74.12 180.27 
Maximal normalized 
score 
826.28 484.14 1,728.21 
Minimal normalized 
score 
7.74 7.6 7.7 
 
 
Dataset S1 
Expressed regions. List of 5,564 expressed regions, their length and locations in the 
genome (NC_009085.1) or plasmids (NC_009083.1 and NC_009084.1) of A. baumannii 
ATCC 17978. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538643/bin/pone.0182084.s008.docx 
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Dataset S2 
Coding regions. List of normalized expression of 255 coding regions (expression score 
should be equal or above 7.6 in some growing condition: Bio, Exp or Sta), their length 
and locations in the genome (NC_009085.1) or plasmid (NC_009084.1) of A. baumannii 
ATCC 17978. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538643/bin/pone.0182084.s009.docx 
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Un análisis transcripcional revela nuevos factores relacionados con la capacidad de 
formar biopelículas de Acinetobacter baumannii. 
Las enfermedades infecciosas se consideran un importante problema de salud pública 
tanto en países desarrollados como en países en vías de desarrollo. La adaptación de las 
bacterias a condiciones de estrés, debido en parte al mal uso de los antibióticos, ha 
propiciado la aparición de cepas multi-resistentes. Esto es especialmente peligroso en el 
ambiente hospitalario, donde los pacientes inmunocomprometidos son muy vulnerables. 
Los patógenos que en la actualidad causan un mayor número de infecciones hospitalarias 
y que son capaces de “escapar” a la acción de los antimicrobianos se engloban dentro del 
término ESKAPE. En este grupo está incluido Acinetobacter baumannii, un cocobacilo 
Gram-negativo que se aísla frecuentemente a partir de  equipos médicos y pacientes 
hospitalizados. La habilidad de esta bacteria de desarrollar factores de virulencia y 
resistencia constituye la clave de su éxito  como patógeno humano. 
A. baumannii causa diversos tipos de infecciones, siendo predominantes las de tracto 
respiratorio. Los pacientes con ventilación mecánica o que han sufrido cirugías son 
especialmente sensibles a este tipo de infecciones. Las tasas de mortalidad asociadas a 
infecciones producidas por A. baumannii son significativamente superiores cuando las 
cepas son resistentes a los carbapenemes. 
La plasticidad genética de A. baumannii le permite adquirir genes de resistencia de otras 
especies y desarrollar mutaciones para adaptarse a condiciones de estrés. La rápida 
emergencia de cepas de A. baumannii resistentes a todos los β-lactámicos, incluyendo los 
carbapenemes, explica el potencial de este microorganismo para responder a la presión 
selectiva del ambiente. Se han detectado infecciones por cepas de esta especie resistentes 
a todos los antibióticos utilizados en clínica, lo que dificulta enormemente su tratamiento. 
Además, el éxito de A. baumannii se puede atribuir a otros factores como su capacidad 
para formar biopelículas y resistir a la desecación en superficies abióticas. La biopelícula 
es una compleja estructura formada por una comunidad de células sésiles embebidas en 
una matriz producida por ellas mismas. Las bacterias que forman parte de las biopelículas 
presentan una serie de características diferentes a las células bacterianas que se 
encuentran en un modo de vida planctónico. Así, las bacterias asociadas a las biopelículas 
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poseen mayor resistencia a los antibióticos, a los desinfectantes y a componentes del 
sistema inmune de los hospedadores. 
La alta capacidad de A. baumannii de adherirse a superficies abióticas y bióticas origina 
el primer paso para la colonización y suele ir acompañado del desarrollo de biopelículas. 
Esta habilidad para adherirse puede variar entre diferentes cepas y está influida por 
diversos factores, tales como la disponibilidad de nutrientes, los componentes de la 
superficie bacteriana u otros factores ambientales.  
Se han identificado varios genes que participan en la adhesión y la capacidad de formar 
biopelículas en A. baumannii. Los pili tipo I, unas estructuras proteicas muy frecuentes en 
la superficie celular de numerosos patógenos, suelen estar involucrados en ambos 
procesos en bacterias Gram-negativas. En A. baumannii se han identificado varios 
operones que codifican pili tipo I, cuya inactivación causa un descenso en la producción 
de biopelículas y en la adherencia. 
Otras muchas proteínas asociadas a la membrana bacteriana están involucradas en estos 
procesos. Así, la proteína autotransportadora Ata, un sistema de secreción tipo V, también 
es necesaria para el desarrollo de biopelículas, la adhesión bacteriana y la supervivencia 
de A. baumannii durante la infección. La adhesina Bap (biofilm-associated protein) es un 
factor importante para la formación de una biopelícula madura y para la adherencia a 
células epiteliales humanas. También la porina de la membrana externa OmpA está 
implicada en la adherencia a plástico y a células eucariotas, además de inducir la 
apoptosis en células epiteliales. 
Los mecanismos de comunicación entre bacterias,  o quorum sensing, también están 
relacionados con la capacidad de adherencia y la formación de biopelículas. Las bacterias 
Gram-negativas utilizan acil-homoserina-lactonas como moléculas señalizadoras. En A. 
baumannii la presencia de estas moléculas provoca un aumento en la densidad de la 
biopelícula y la degradación de las acil-homoserín-lactonas interrumpe su formación. 
La cantidad de biopelícula formada por A. baumannii también se ve alterada por señales 
ambientales diversas como la temperatura, la luz, la concentración de hierro disponible o 
la superficie sobre la que se forma. 
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Los procesos biológicos bacterianos están regulados a distintos niveles. Existen pequeñas 
moléculas  de RNA (sRNAs) que actúan como reguladores modulando la transcripción, la 
traducción y la estabilidad del RNA mensajero (mRNA). Los sRNAs ejercen su acción 
mediante diferentes mecanismos; provocando cambios en la conformación del RNA, 
uniéndose a proteínas o a otros RNAs por emparejamiento de bases o interaccionando con 
el DNA. Los sRNAs mejor caracterizados son los que regulan la expresión génica 
mediante emparejamiento de bases con el mRNA. 
La formación de biopelículas es uno de los procesos biológicos más complejos que llevan 
a cabo las bacterias, por lo que su activación debe responder de manera precisa a cambios 
ambientales. Aparte de la regulación transcripcional que controla la producción de 
biopelículas, existe una regulación post-transcripcional mediada por sRNAs que permite a 
la bacteria adaptarse rápidamente a las variaciones del entorno. Se han identificado 
numerosos sRNAs capaces de integrar distintas señales y actuar como reguladores que 
controlan la formación de biopelículas, especialmente en Escherichia coli. Además, 
muchos de estos sRNAs participan también en la coordinación de diversos procesos como 
el metabolismo celular, la virulencia o la resistencia a antibióticos. 
En la actualidad la información sobre la regulación mediada por sRNAs en A. baumannii 
es escasa. Se han identificado una serie de sRNAs, mediante métodos bioinformáticos y 
de secuenciación masiva, pero no se conocen los procesos biológicos en los que podrían 
estar implicados. 
En el presente trabajo se realizó un análisis transcripcional empleando técnicas de 
secuenciación masiva usando como material de partida la totalidad de las moléculas de 
mRNA y de sRNA extraídas a partir de células de la cepa A. baumannii ATCC 17978 
tanto asociadas a biopelículas como planctónicas (en fases de crecimiento exponencial y 
estacionaria). Esto ha permitido la identificación de varios nuevos factores implicados en 
el proceso de formación de biopelículas. 
Los resultados obtenidos mostraron que, aunque muchos genes se expresaban de manera 
constitutiva tanto en biopelículas como en células planctónicas, muchos otros presentaban 
una expresión diferencial en células sésiles con respecto a las bacterias plantónicas. Un 
total de 1621 genes aparecieron sobre-expresados en las células asociadas a biopelícula 
con respecto a las células planctónicas. Además, 55 genes se detectaron exclusivamente 
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en células sésiles, estando totalmente inhibidos en células planctónicas. Una vez 
clasificados los genes sobre-expresados en las biopelículas en función de los procesos 
biológicos en los que participaban, se observó que el grupo mayoritario era el implicado 
en regulación transcripcional. Otros grupos de genes sobre-expresados resultaron estar 
relacionados con el metabolismo de aminoácidos, el metabolismo de ácidos grasos, el 
transporte de iones, la biosíntesis de carbohidratos o la respuesta al estrés. 
Muchos de estos genes codifican proteínas cuya función ya se había relacionado 
previamente con procesos de formación y mantenimiento de las biopelículas, mientras 
que otros se detectaron en este trabajo por primera vez. Entre estos genes relacionados 
con la formación de biopelículas en A. baumannii, aparecieron varios genes del operón 
csuA/BABCDE y el gen bfmR, que forma parte de un sistema regulador de dos 
componentes y controla la expresión de los genes de dicho operón. Asimismo, se observó 
la sobre-expresión de genes relacionados con la formación de pili; como el gen 
A1S_1507, que codifica una proteína de una fimbria, y el gen A1S_3168, que codifica la 
proteína de formación de pilus PilW. 
Un importante número de genes relacionados con el transporte y la captación de hierro se 
encontraron sobre-expresados en las células asociadas a biopelículas en comparación con 
las células planctónicas. Así, se encontraron, entre otros, un receptor de una 
enterobactina, una proteína de unión a hierro, un receptor de una acinetobactina, una 
proteína de síntesis de un sideróforo o una proteína de síntesis de acinetobactina. Además, 
algunos de estos genes, como los relacionados con la acinetobactina (A1S_2380 y 
A1S_2388), estaban exclusivamente expresados en biopelículas y no se detectaron en las 
muestras de células plantónicas. 
Otro factor muy implicado en la formación de biopelículas es la proteína Bap que, en A. 
baumannii ATCC 17978, se encuentra codificada por dos loci homólogos, los genes 
A1S_2724 y A1S_2696. Ambos genes se encontraron sobre-expresados en células sésiles 
en comparación con células planctónicas, por lo que se sugiere que las proteínas 
codificadas por estos genes podrían estar implicadas en la formación de biopelículas en la 
cepa ATCC 17978. 
La homoserín-lactona sintasa, codificada por el gen A1S_0109, responsable de la síntesis 
de la acil-homoserín-lactona, y que ha sido descrita como necesaria para la formación de 
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biopelículas, presentó unos niveles de expresión mayor en biopelículas. Asimismo, el 
grupo de genes contiguo a esta sintasa (A1S_0112-A1S_0118) resultaron estar también 
sobre-expresados en células sésiles, destacando entre ellos el gen A1S_0114, que codifica 
una proteína transportadora de grupos acilo, y que presentó los niveles de expresión más 
altos detectados en células asociadas a biopelículas (de orden de 120 veces más). 
Se seleccionaron 5 genes entre los genes sobre-expresados en biopelículas. Estos fueron 
los genes A1S_1507, A1S_3168, A1S_2042, A1S_0302 y A1S_0114 que codifican una 
proteína de fimbria, una proteína de un pilus, un regulador transcripcional, una proteína 
hipotética y un transportador de grupos acilo, respectivamente. Mediante RT-qPCR se 
confirmaron los resultados obtenidos a partir del análisis transcripcional masivo y se 
elaboraron cepas mutantes por disrupción de los genes de interés con el plásmido pCR-
Blunt-II-TOPO. El análisis de la formación de biopelículas de las cepas mutantes reveló 
un descenso en el caso de las cepas mutantes con respecto a la cepa salvaje A. baumannii 
ATCC 17978, confirmándose el papel de estos genes en el proceso de formación de 
biopelículas. 
Se elaboró un mutante estable libre de marcadores de resistencia a antibióticos 
eliminando permanentemente el gen A1S_0114. El mutante estable, que carece del gen 
A1S_0114, mostró una capacidad para formar biopelículas unas tres veces menor a la de 
la cepa salvaje. Además, este mutante estable permitió analizar la relación del gen 
A1S_0114 con los genes próximos A1S_0109, A1S_0112 y A1S_0113, que codifican 
una homoserín-lactona sintasa, una acil-CoA sintasa y una acyl-CoA deshidrogenasa, 
respectivamente. Mediante qRT-PCR se demostró que en ausencia del gen A1S_0114, la 
expresión de los otros genes descendía en células en fase estacionaria de crecimiento. 
Estos resultados sugieren que el gen A1S_0114 podría estar involucrado en la formación 
de biopelículas a través de mecanismos de quorum sensing, aunque se postula que su 
actividad como donador de grupos acilo podría estar también relacionada con el 
metabolismo de ácidos grasos. 
Con el fin de caracterizar el gen A1S_0114 y conocer su papel en la patogénesis y de 
establecer su relación con los genes adyacentes se realizaron una serie de análisis 
genotípicos y fenotípicos. 
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Tanto los datos del análisis transcriptómico masivo como un análisis in silico del grupo 
de genes A1S_0112-0119 sugerían que estos genes podrían estar actuando como un 
operón policistrónico, ya que presentaban niveles de sobre-expresión semejantes en 
células asociadas a biopelículas, estando localizados  próximos  en la misma orientación. 
Se confirmó la naturaleza policistrónica del operón mediante técnicas de RT-PCR 
utilizando oligonucleótidos que conectaban todos los genes. 
Se llevaron a cabo ensayos de adherencia a células epiteliales alveolares humanas A549 
para evaluar los efectos biológicos causados por la eliminación del gen A1S_0114. Estos 
experimentos mostraron que la cantidad de bacterias de la cepa mutante recuperadas era 
un 60% inferior a los recuentos de células alveolares infectadas con la cepa salvaje ATCC 
17978. Cuando el mutante estable se complementaba con el plásmido pWH1266-Km 
portador de una copia del gen A1S_0114, la capacidad de adherencia de la cepa mutante 
se restauraba parcialmente. 
Los resultados obtenidos en los experimentos de adherencia a células alveolares humanas 
se confirmaron mediante microscopía electrónica de barrido. El análisis de células A549 
polarizadas infectadas corroboraron el papel del gen A1S_0114 en la adherencia a 
superficies bióticas. Las células A549 infectadas con la cepa salvaje A. baumannii ATCC 
17978 presentaban importantes daños tanto a nivel celular como en la  capa de surfactante 
que las recubre. Además, se detectó un gran número de bacterias adheridas a la superficie 
de las células alveolares. Por su parte, la infección causada por la cepa mutante provocó 
importantes daños celulares y en la capa de surfactante, pero apenas se detectaron 
bacterias adheridas a la superficie de las células polarizadas. 
También se utilizó la microscopía electrónica de barrido para respaldar los resultados de 
formación de biopelículas. Tal y como se esperaba, las micrografías mostraron una mayor 
capacidad de las células de la cepa salvaje ATCC 17978 para adherirse a la superficie 
abiótica y configurar estructuras multicelulares y tridimensionales, que se asocian con la 
formación de biopelículas maduras. Por el contrario, sólo se detectaron pequeñas 
agrupaciones no tridimensionales de bacterias en el caso de la cepa mutante. 
Debido a que la eliminación del gen A1S_0114 afecta a la capacidad de A. baumannii 
para adherirse y formar biopelículas, se realizó un análisis de los niveles de expresión de 
genes relacionados con estas funciones. Se seleccionaron el gen que codifica la proteína 
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de membrana OmpA y los genes asociados a sistemas de pili csuA/B, A1S_0690, 
A1S_1510 y A1S_2091. La RT-qPCR comparativa entre la cepa salvaje ATCC 17978 y 
el mutante estable demostró que la expresión de los genes de pili se reducía de forma 
estadísticamente significativa en la cepa carente del gen A1S_0114, excepto en el caso de 
csuA/B, cuya expresión aumentaba en la cepa mutante. Sin embargo, este último dato 
podría no ser muy relevante, ya que el gen csuA/B parece estar truncado en la cepa ATCC 
17978. La eliminación del gen A1S_0114 también causó una pequeña reducción de la 
expresión del gen ompA. 
El papel que juega el gen A1S_0114 en virulencia se evaluó mediante diferentes modelos 
animales: un ensayo de fertilidad en Caenorhabditis elegans, un experimento de 
supervivencia en la oruga Galleria mellonella y un modelo de neumonía en ratón. El 
estudio de fertilidad en C. elegans demostró que el número de huevos viables era casi dos 
veces superior en gusanos infectados con la cepa mutante en comparación con la cepa 
salvaje ATCC 17978. Un 50% de las larvas de G. mellonella infectadas con la cepa 
salvaje murieron a los 5 días de ser infectadas, mientras que el porcentaje de muerte entre 
las larvas infectadas con el mutante estable fue significativamente menor. El modelo de 
neumonía mostró que la carga bacteriana en los pulmones de ratones infectados con la 
cepa mutante era significativamente inferior a la de los animales infectados con la cepa 
salvaje ATCC 17978. Los resultados de estos experimentos evidencian que el gen 
A1S_0114 contribuye a la virulencia de A. baumannii. 
Debido a la implicación del gen A1S_0114 en virulencia y a la predicción de que los 
genes del operón A1S_0112-0119 podrían actuar como una péptido sintasa no ribosomal, 
se realizó una búsqueda de compuestos que podrían estar producidos por este operón 
mediante cromatografía líquida/espectrometría de masas. Dicho análisis mostró la 
presencia de un compuesto de peso molecular de 505,28 Da presente en las muestras de la 
cepa salvaje ATCC 17978, no detectado en el caso de la cepa mutante. La fórmula 
molecular de dicho compuesto, que hemos denominado Acinetina 505, es C23H43N3O7S y 
resultó ser semejante a un lipopéptido de tres aminoácidos. 
Los datos demuestran que el gen A1S_0114 afecta a la formación de biopelículas, a la 
adherencia y a la virulencia de A. baumannii. Sin embargo, todavía no hemos conseguido 
desentrañar el mecanismo mediante el cual se regulan estos procesos y el papel de la 
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Acinetina 505 en dicha regulación. . Ahondar en estos aspectos podría aportar 
importantes datos sobre la patobiología de A. baumannii y facilitar el desarrollo de 
herramientas alternativas para el tratamiento de infecciones causadas por este patógeno. 
A continuación, se utilizaron técnicas de secuenciación masiva para caracterizar el 
transcriptoma global  a nivel de sRNAs en células sésiles y planctónicas de  A. baumannii 
ATCC 17978. Se compararon los transcriptomas de sRNA de células planctónicas 
obtenidos en fases de crecimiento exponencial y estacionario y de células asociadas a 
biopelículas para identificar diferencias en los perfiles de expresión de sRNAs. 
Se identificaron un total de 5.564 presuntos sRNAs, fragmentos de RNA no coincidentes 
con ningún gen previamente descrito ni con RNA transferentes ni ribosómicos. Un total 
de 255 de estos sRNAs se describieron como expresados diferencialmente en alguna de 
las tres condiciones de crecimiento. Todos ellos estaban localizados en el cromosoma 
bacteriano excepto uno, localizado en el plásmido pAB2. En células asociadas a 
biopelículas, 28 sRNAs estaban sobre-expresados mientras que 32 tenían una expresión 
menor que en células planctónicas. Uno de ellos, el sRNA 13573, mostró unos valores de 
sobre-expresión de unas 120 veces más en biopelículas con respecto a células 
planctónicas. Además, 9 sRNAs fueron detectados únicamente en células de biopelículas 
mientras que 21 se expresaron exclusivamente en células planctónicas. Los resultados de 
secuenciación masiva de 6 de los sRNAs únicamente expresados en biopelículas y del 
sRNA 13573 se corroboraron mediante RT-qPCR. 
El alto nivel de expresión del sRNA 13573 en células sésiles sugería su posible papel en 
la regulación de las biopelículas. Se elaboró una cepa mutante estable que carecía del 
sRNA 13573, así como una cepa que sobre-expresaba el sRNA 13573 desde un plásmido, 
con el fin de dilucidar el papel de este sRNA en la patogénesis de A. baumannii. Los 
experimentos de formación de biopelículas mostraron que la falta del sRNA 13573 
provocó una pequeña pero no significativa reducción de la producción de biopelícula. Sin 
embargo, la cepa que sobre-expresaba el sRNA 13573 duplicó la formación de 
biopelícula con respecto a la cepa salvaje ATCC 17978. Las imágenes de microscopía 
electrónica de barrido mostraron que las células que sobre-expresaban el sRNA 13573 
eran capaces de desarrollar biopelículas con estructuras tridimensionales, a diferencia de 
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la cepa salvaje que presentaba estructuras más simples. Las células de la cepa mutante 
mostraron un patrón más desorganizado que las de la cepa ATCC 17978. 
Los ensayos de adhesión a células eucariotas epiteliales A549 indicaron que la sobre-
expresión del sRNA 13573 provocaba un aumento de la adherencia de unas 30 veces 
superior a la cepa salvaje. La capacidad de adherirse disminuyó en la cepa que carecía del 
sRNA 13573, pero este efecto se restableció en la cepa mutante complementada, 
portadora de una copia del sRNA 13573 en el plásmido pETRA, alcanzando valores 
superiores a la cepa salvaje. Un análisis por microscopía electrónica de barrido de células 
alveolares humanas polarizadas infectadas con las distintas cepas reveló que la sobre-
expresión del sRNA 13573 confería a la bacteria una espectacular capacidad de formar 
biopelículas con estructura tridimensional sobre las células epiteliales. Tal y como se 
esperaba, la cepa mutante mostró una menor adherencia a las células eucariotas que la 
cepa ATCC 17978. 
Los datos recogidos en este trabajo indican que el transcriptoma de sRNAs presenta un 
patrón de expresión diferente en células asociadas a biopelículas en comparación con 
células planctónicas. Además, se ha confirmado que el sRNA 13573, altamente expresado 
en células asociadas a biopelículas, está implicado en la formación de biopelículas así 
como en la adherencia a superficies tanto abióticas como bióticas. 
En conclusión, en el presente trabajo se ha demostrado que el  patrón de mRNA de las 
células asociadas a biopelículas de A. baumannii ATCC 17978  es significativamente 
diferente al de las células planctónicas. Se han identificado una serie de genes que 
participan en la regulación de las biopelículas, destacando entre ellos el gen A1S_0114, 
que codifica una proteína transportadora de grupos acilo, y que  juega un importante 
papel en adherencia a superficies bióticas y abióticas, virulencia y biosíntesis del 
metabolito Acinetina 505. Además, se han descrito un importante número de sRNAs en la 
cepa A. baumannii ATCC 17978, encontrándose muchos de ellos expresados de forma 
diferencial en células sésiles con respecto a células en fase exponencial o estacionaria. 
Entre los nuevos sRNAs descritos, se encontró el sRNA 13573, demostrándose su 
implicación en la regulación de la formación de biopelículas y en la adherencia a células 
eucariotas. Este trabajo sirve como base para futuros estudios que traten de desentrañar la 
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compleja red que regula tanto la formación de biopelículas como otros procesos 
biológicos asociados a la patogénesis de A. baumannii. 
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